
















The Dissertation Committee for Clara Leigh Feider Certifies that this is the 
approved version of the following Dissertation: 
 
Advanced development of ambient ionization mass spectrometry imaging methods 





























Advanced development of ambient ionization mass spectrometry imaging methods 









Presented to the Faculty of the Graduate School of  
The University of Texas at Austin 
in Partial Fulfillment  
of the Requirements 
for the Degree of  
 








To my loving grandfather, Leroy Feider, who has selflessly supported all my endeavors 





There are so many people in my life that deserve recognition for what they have 
done for me during my path to obtaining my PhD. It would not be right of me to take the 
credit for an accomplishment that we all share. First, I would like to thank my entire 
family for their constant support, specifically my parents Robert and Teri, my grandfather 
Leroy, and my sister Annabel. Dad, you have always taught me that I can accomplish 
anything I set my mind to and I attribute my analytical mind and quest for knowledge to 
you. Mom, you have always supported me and never stopped promoting me and my 
accomplishments to anyone who was around to listen. Your desire to understand and 
learn from me was a humbling experience. Nonno, without you, none of my 
accomplishments would be possible. You have given selflessly to me more times than I 
can count so that I may follow my dreams and lead a life filled with joy and success. You 
are the greatest man I have ever known. Annabel, thank you for paving the way in our 
family and teaching me to follow my own path in life without regard for what others may 
believe. Thank you all for your love, support, and advice throughout my entire education. 
This would not have been possible without you. I love you so much. 
To my advisor Prof. Livia S. Eberlin, I cannot express how thankful I am to you 
for helping me reach this milestone. You have taught me so much more than simply how 
to be a scientist. I admire your dedication, your perseverance, and your commitment to us 
and your family. You have always said that I have grown so much in the last five years, 
and I want you to know that you have inspired that growth. Thank you from the bottom 
of my heart for saying yes when I asked to be your first student, it has changed my life in 
many ways. I hope that I have made you proud.  To my committee members, Dr. Jennifer 
 vi 
Brodbelt, Dr. Richard Crooks, and Dr. Tom Milner, thank you for your time and support 
throughout my PhD.    
To my amazing research group, I love you all so much. We have been through so 
many ups and downs together while building this lab into something we should all be 
very proud of. Marta, thank you for being my other half on this PhD journey. We have 
shared so many moments together during the last five years and there is no one I would 
have rather had by my side that entire time. Jialing and Sunil, thank you for teaching me 
everything I know about mass spectrometry. Your mentorship and guidance was always 
appreciated and I have learned so much from our friendships. To Kyana, Rachel, and 
Alena, I loved getting to expand our little group with you three. You all inspired me to be 
better so that I could help you get better too. To Anna, Mary, and Abby, each of you 
brought something extremely special to our group: Anna brought the banter, Mary 
brought the puns, and Abby brought the sass. Thank you for making our lab the most fun 
place to work. To Mike, Sydney, Monica, and Meredith, I am so proud of what you four 
have accomplished thus far and I can’t wait to see what you will do in the future. To all 
of our undergraduate students and past group members that have helped with many 
projects throughout my time here, including Jonathan Young, John Lin, Natalia Elizondo, 
Ofer Koren, Ashish Chakraborty, and Prajwal Gowda, your hard work did not go 
unnoticed or unappreciated and I wouldn’t be here without you. I was so blessed to have 
you all as my friends and coworkers the last five years, and I don’t think I will ever find a 
group of people I appreciate more than you all. 
To my fantastic collaborators, this work would not have been possible without 
your ideas, knowledge, resources, and time. To those at Seton Medical Center, including 
Dr. Michael Breen, Dr. Suzanne Ledet, Katherine Sebastian, Loren Cain, and Faith Ozer, 
I appreciate your dedication that has allowed for me to work on a project that I believe 
 vii 
truly matters. To those within research labs at the University of Texas who have shared 
their resources and experience, including Dr. Jennifer Brodbelt, Dr. Dustin Klein, Luis 
Macias, Dr. Richard Crooks, Collin Davies, Logan Wilder, and Spencer Woody, I am 
thankful that you believed in my ideas and helped me bring them to fruition. And to those 
within my own research lab that went above and beyond to help me accomplish my goals 
and have assisted in the publications within this dissertation, specifically Kyana Garza, 
Anna Krieger, Rachel DeHoog, Marta Sans, and Jialing Zhang, I am forever grateful for 
your support. 
To Mason Valentine, never in my wildest dreams did I think part of getting my 
PhD would be meeting you. You and I have done this together, and I can’t imagine it any 
other way. Thank you for your love, your support, your jokes, and your constant presence 
in my life. I am so happy that we have shared this together and picked up our two buddies 
Kevin and Jasper along the way. I am excited to see what the future holds for us.  
Thank you all once again for just being here with me throughout the last five 







Advanced development of ambient ionization mass spectrometry imaging methods 
and their utilization towards the understanding of metabolic diseases 
 
Clara Leigh Feider, Ph.D. 
The University of Texas at Austin, 2020 
 
Supervisor:  Livia S. Eberlin 
 
Ambient ionization mass spectrometry (MS) technologies offer a unique 
opportunity to bring the specificity and sensitivity of MS into clinics, potentially allowing 
rapid analyses of biospecimens without need for sample preparation or highly trained 
personnel. As these technologies offer significant advantages over current technologies in 
terms of speed and suitability for a hospital environment, ambient ionization methods 
have been applied to a wide variety of clinical applications such as disease diagnosis, 
therapeutic drug monitoring, and biomarker discovery. Despite these successes, there 
remain challenges for these methods to overcome before they can be relied upon for 
routine analysis of patient samples. Prior to their use by physicians to inform decisions 
regarding patient care, ambient ionization MS technologies must be robust, versatile, and 
be shown to improve patient outcomes by providing information that is lacking in current 
standard of care procedures. 
This dissertation serves to outline recent advancements made towards the 
improvements of ambient ionization MS technologies as well as the application of these 
 ix 
techniques towards disease indications that have yet to be explored. Chapter 2 provides 
data and discussion about how relative humidity can contribute to variability and poor 
data quality during desorption electrospray ionization (DESI) MS experiments, providing 
essential information about how atmospheric conditions can contribute to the robustness 
of the technique. Chapters 3 and 4 present methods for integration of new separation and 
fragmentation techniques with ambient ionization methods in order to increase the 
amount of information that can be gathered from a biological specimen. Finally, Chapter 
5 presents results from the utilization of DESI-MS imaging towards understanding 
endometriosis, a chronic gynecological condition that has limited diagnosis and treatment 
options for patients. The entirety of this work aims to discuss how further improvements 
to ambient ionization MS technologies can make them useful for understanding a wider 
variety of disease processes and the progress that is being made to this end. 
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Chapter 1: Introduction 
1.1 MASS SPECTROMETRY FOR THE MOLECULAR UNDERSTANDING OF DISEASED TISSUE 
SAMPLES 
Mass spectrometry (MS) has become a powerful tool for the investigation of the 
molecular composition of biological samples and to further understand the alterations 
within these chemical environments during times of dysregulated function. As mass 
spectrometers have increased in performance and decreased in size and costs, they have 
become an integral part of clinicals labs. The versatility, sensitivity, and specificity of 
mass spectrometers make them the ideal tool for the development of assays for the 
detection and diagnosis of many diseases from nearly any biological matrix. Methods 
have been implemented in clinical laboratories for the analysis of metabolites, lipids, and 
proteins from human samples to diagnosis a variety of ailments such as bacterial 
infections1, prostate cancer2, and adverse cardiac events3, and research is currently 
ongoing to develop new MS biomarker detection assays. 
The two most widely implemented MS techniques for biological sample assays 
and disease diagnosis are liquid chromatography mass spectrometry (LC-MS) and matrix 
assisted laser desorption/ionization mass spectrometry (MALDI-MS).  LC-MS is a robust 
analytical tool that utilizes a liquid separation step to concentrate analytes of interest and 
remove unwanted contaminants within the sample. As analytes flow out of the separation 
column, they are introduced into the mass spectrometer by an ionization source. 
Electrospray ionization (ESI) is the most commonly used ionization source that is 
coupled to liquid chromatography, but other sources such as atmospheric pressure 
chemical ionization (APCI) and atmospheric pressure photoionization (APPI) can be used 
for specific applications. Chromatographic separation of analytes allows for low limits of 
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detection of analytes as well as the possibility of quantitative analysis of biomarkers 
within clinical samples.4 However, LC-MS is limited to the analysis of liquid samples 
and often requires extensive sample preparation prior to introduction into the instrument 
to prevent contamination and clogging of the chromatography system and mass 
spectrometer, limiting throughput. Further, very targeted and standardized methods must 
be developed to analyze specific compounds and different molecular classes require 
significantly different separation and analytical parameters.5 In MALDI-MS, a light-
absorbing matrix is applied to the surface of a sample which can then be ablated with an 
ultraviolet laser, releasing analytes from the sample for MS analysis. MALDI-MS is 
advantageous in a clinical setting as it allows for direct analysis of both liquid and solid 
samples, reducing the need for extensive sample clean-up prior to analysis. Additionally, 
as MALDI-MS is not coupled to a chromatographic separation step, analysis of an entire 
molecular profile containing multiple molecular classes is possible and allows for simple 
biomarker discovery. The disadvantages of MALDI-MS, however, make it a less 
desirable clinical tool. For example, the matrix used for each application must be 
optimized for the sample type and the matrix application step can be time consuming and 
utilizes harmful chemicals.6 Moreover, MALDI-MS is traditionally performed within a 
high vacuum apparatus which can further complicate introduction into a fast-paced 
clinical workflow.  
 A significant advancement in the field of clinical MS is the development of MS 
imaging, a technique in which a two-dimensional sample is rastered beneath an ionization 
source to collect MS data on a spot-by-spot basis, generating chemical maps of the 
species within a sample. MS imaging has been employed for a variety of applications but 
has shown highest promise in the field of biological tissue imaging as molecular 
information generated can be directly correlated to histological features within thin tissue 
 3 
sections. MS imaging using MALDI-MS as well as secondary ion mass spectrometry 
(SIMS) has revolutionized the field of histological imaging, allowing for label-free and 
multiplexed interrogation of cell populations and tissue microenvironments for 
applications in disease diagnosis and clinical research.7 Applications of MS imaging in 
clinical research have been wide reaching, spanning from distinguishing breast cancer 
molecular subtypes8-10 to investigation of molecular alterations occurring with respect to 
pathogenic infections.11,12 Further advancements in laser and ion beam technologies as 
well as histological image fusion algorithms have allowed for sub-micron pixel size for 
molecular ion images,13-15 rapidly closing the resolution gap between MS imaging and 
traditional histological staining. Therefore, advanced development of these molecular 
imaging technologies could allow for future use of MS imaging in clinical laboratories. 
1.2 AMBIENT IONIZATION MASS SPECTROMETRY IMAGING OF BIOLOGICAL TISSUE 
SECTIONS 
The early 2000s brought a new age in the field with the introduction of ambient 
ionization MS techniques. Ambient ionization refers to “the ionization of unprocessed or 
minimally modified samples in their native environment, and it typically refers to the 
ionization of condensed phase samples in air.” A wide variety of ambient ionization MS 
methods using versatile forms of energy to generate molecular ions have been developed, 
greatly expanding the use of these technologies while improving their performance for a 
range of applications (Illustration 1.1). However, one of the most prominent and most 





Illustration 1.1. Representation of the different modes of desorption/ionization typically 
used in ambient ionization techniques. 
 Pictured in the center wheel, and a variety of applications these methods can be 
used for, illustrated in the outer wheel of the figure. In this dissertation, the primary 
methods used are solvent extractions techniques applied to biomedical research 
applications. This figure is reprinted with permission from “Feider, C. L.; Krieger, A.; 
DeHoog, R. J.; Eberlin, L. S., Ambient Ionization Mass Spectrometry: Recent 
Developments and Applications. Analytical Chemistry 2019, 91 (7), 4266-4290.” 






analysis within a clinical environment. Due to the minimal sample preparation steps 
required to generate molecular ions as well as the ability to perform these types of 
analyses in the open atmosphere, ambient ionization MS techniques are well suited for a 
clinical lab. Liquid extraction based ambient ionization techniques, in particular, have 
become the most widely used subclass of ambient ionization MS technologies for the 
analysis of biological sample due to their efficiency in generating molecular ions for 
many biological species such as metabolites, lipids, and proteins.16 Additionally, most 
solvent-based ambient MS methods utilize an ESI mechanism, a soft ionization method 
that results in the generation of intact molecular ions which can be much more easily 
interpreted and directly correlated to biological processes.17  Desorption electrospray 
ionization (DESI) was the first liquid extraction based ambient ionization MS method 
developed and is the most well-established of the techniques for the analysis of biological 
tissue sections.18-20 DESI-MS utilizes a spray of charged solvent droplets to bombard a 
tissue surface and desorb analytes from the sample. The solvent-encapsulated molecules 
are then directed towards the inlet of the mass spectrometer, during which time the 
droplets undergo evaporation and coulombic explosion until the molecular ions are 
desolvated and can traverse through the mass spectrometer to the mass analyzer. 
Similarly to MALDI-MS, the DESI source can then be mounted onto a moving platform 
that can raster the sample beneath the solvent spray in two-dimensions, allowing for 
spatial mapping of the molecules within a sample. Further, use of histologically 
compatible solvent systems that allow for DESI- MS analysis without disrupting the 
cellular structure of tissue sections have facilitated direct comparison of pathological and 
molecular information from the same sample.21 Therefore, DESI-MS is an ideal tool for 
the investigation of the lipid and metabolite composition of tissue samples and correlation 
of these molecular patterns to the disease state of the sample. DESI-MS has been 
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employed extensively to this end to facilitate the understanding of a variety of diseases, 
but efforts have been primarily focused on distinguishing between normal and cancerous 
tissue. Many cancers, including breast22,23, ovarian24,25, prostate26, thyroid27,28, and 
brain20,29,30, among others, have been analyzed with DESI-MS, showing significant 
alterations in the molecular profiles between healthy and tumor tissues. The ability to 
distinguish cancerous and normal tissues with DESI-MS has encouraged the expansion of 
potential clinical applications for the technology, with recent work using the method for 
the investigation of metabolic changes associated with multiple sclerosis and cardiac 
ischemia.31,32 Further development and utilization of DESI-MS should allow for an 
increased use of this technology for a larger breadth of clinical applications outside of 
cancer diagnosis. 
1.3 RESEARCH AIMS 
While ambient ionization MS imaging technologies have undergone significant 
development and improvement since their inception, limitations in their capabilities have 
hampered their use for many clinical applications. Further understanding and advanced 
modifications of ambient ionization MS methods to increase the reliability, sensitivity, 
and specificity of will improve the likelihood of these technologies being implemented in 
the clinic. Within this goal, my research has been focused on integrating ambient 
ionization techniques with various separation, ionization, and activation methods to 
develop methods for using ambient ionization for novel applications.  The main 
objectives were to ensure DESI-MS data is reliable under fluctuating ambient conditions, 
coupling multiple ambient ionization methods to gas phase separations to improve ion 
selectivity, and integrate high energy activation methods into a DESI workflow for in 
depth lipid characterization. Finally, I employed DESI-MS imaging to increase the 
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biological understanding of endometriosis, a benign gynecological condition with severe 
health impacts for patients. 
1.3.1 Effects of humidity on DESI-MS data quality 
While DESI-MS is termed an ambient ionization MS technique and can 
hypothetically be applied in an open-air environment, atmospheric conditions that vary 
by location can have detrimental affects on the performance of the ionization method. As 
MS imaging data interpretation and analysis relies heavily on relative abundance 
measurements, stability and consistency of the DESI-MS spray system is of the utmost 
importance. Alterations in the performance of other ambient ionization techniques 
including direct analysis in real time (DART) and flowing atmospheric pressure 
afterglow (FAPA), regarding atmospheric temperature, pressure, and moisture have been 
explored, but these factors have not been evaluated for DESI-MS. Chapter 2 of my 
dissertation chronicles a period of time within the Eberlin laboratory during which the 
signal from our DESI-MS system was extremely variable and unreliable with no direct 
cause. Upon systematic evaluation of source and instrument parameters, the cause of the 
instability was attributed to the significant fluctuations in relative humidity that were 
occurring within the laboratory. This discovery suggests that not every environment is 
suitable for DESI-MS analysis and that there is much more to understand about ambient 
ionization techniques before they can be implemented for fieldable and clinical 
applications.  
1.3.2 Incorporating gas-phase separations into MS imaging workflows 
Ambient ionization MS techniques have the advantage of untargeted analysis of 
small molecules from nearly any sample surface, making these methods broadly 
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applicable. However, this advantage is directly correlated to the major significant 
disadvantage of ambient ionization and MS imaging technologies: ion suppression 
resulting from a complex matrix.  As traditional ambient ionization MS methods do not 
incorporate and liquid chromatographic separation of analytes prior to introduction into 
the mass spectrometer for analysis, all the molecules from a sample are ionization and 
analyzed simultaneously. This can lead to competitive ionization during the ESI process 
or the filling of trap-based mass analyzers with the most abundant species in a sample, 
resulting in lower abundance of less easily ionizable or lower abundance species. 
Additionally, complex matrices can contain salts and contaminants that can further 
suppress the ion signal from the analytes of interest, reducing the sensitivity of the mass 
spectrometer and resulting in higher detection limits. Due to the definition of ambient 
ionization MS, coupling to a traditional chromatographic separation or incorporating 
sample preparation steps to limits these matrix effects are not desired. Therefore, 
separation methods that occur post-ionization and on a micro- to millisecond time scale 
have been explored for increasing the sensitivity and selectivity of ambient ionization 
methods. 
Chapter 2 of my dissertation describes the integration of two ambient ionization 
MS imaging techniques, DESI and liquid micro-junction surface sampling probe (LMJ-
SSP), with high field asymmetric waveform ion mobility spectrometer (FAIMS) to allow 
for semi-selective analysis of analytes of interest during an imaging experiment. FAIMS 
is a gas phase separation method that allows for separation of ions based on their 
differential mobility, a property that is inherent to the ion and is orthogonal to the mass-
to-charge ratio. Essentially, FAIMS can serve as an ion filter for certain classes of 
molecules by applying appropriate voltages to the device, allowing for semi-selective 
analysis of ions without increasing the time needed for the experiment. By coupling 
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FAIMS to ambient ionization MS techniques, we were able to increase the sensitivity for 
certain analytes from human and mice biological tissue sections, namely multiply 
charged complex lipids and biopolymers, while also decreasing the noise resulting from 
the complex matrix. Using the FAIMS integrated platforms during an imaging 
experiment allowed for increased contrast of the analytes to the noise within the ion 
images. Coupling of ambient ionization techniques to methods for gas-phase separation, 
as explored in this study, is a significant advance towards using these analysis tools for a 
wider variety of applications and analytes, therefore increasing the usefulness of these 
technologies for biological sample analysis. 
1.3.3. In depth characterization of lipids directly correlated to histological features 
DESI-MS imaging allows for detection of a wide variety of molecules in a single 
experiment, yielding molecular profiles that encompass a large portion of the analytes 
within a tissue section. The use of high resolution and high mass accuracy mass 
spectrometers further facilitates the molecular characterization of these tissues as they 
enable mass-to-charge separation of species with identical nominal mass values. 
However, isomers at the same exact mass cannot be deconvoluted from one another 
during this type of analysis and require tandem MS measurements for identification. 
Tandem MS, while a valuable tool for the identification of many analytes, is still limited 
in its ability to resolve the structure of all species. The most common activation methods 
for tandem MS experiments are collisional activation techniques, primarily collision 
induced dissociation (CID) and higher energy collisional dissociation (HCD), which rely 
on excitation of analytes and subsequent impaction with a collisional gas. The energy 
stemming from multiple collisions results in fragmentation of the labile bonds. This 
method is limited by this fact, as not all isomers can be identified by fragmentation of the 
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most fragile bonds. For example, glycerol lipid isomers can differ in the number of 
double bonds within each fatty acid chain, the location and the stereochemistry of the 
double bonds within each chain. Collisional activation can identify the number of double 
bonds in each chain through fragmentation of the C-O bond that connects the fatty acid to 
the glycerol, but no diagnostic fragments that reveal the double bond location or 
stereochemistry are produced. This results in a lack of complete understanding of the 
molecular composition of samples and how those compositions may be altered with 
disease. 
In collaboration with Luis Macias and Dustin Klein from the research group of 
Prof. Jennifer Brodbelt, we have developed methods for lipid double bond 
characterization during DESI-MS imaging analyses by integrating with Ultraviolet 
Photodissociation (UVPD). UVPD is an increased energy activation method in which 
ultraviolet photons are absorbed by the analytes, triggering fragmentation. Fragmentation 
by UVPD typically results from the absorbance of one high energy photon, allowing for 
access to an increased number of fragmentation pathways that can often generate more 
informative fragments than the lower energy collisional activation methods. When lipids 
are subject to UVPD irradiation, fragmentation along the carbon chains of the fatty acids 
occurs and yields fragments that are indicative of the double bond placement. Chapter 4 
of this dissertation focuses on the development of a method for online double bond 
characterization within free fatty acids by reactive DESI and charge remote UVPD 
fragmentation. This method was then applied to investigating fatty acid double bond 
position within histological and molecular subtypes of breast tumors, furthering the 
understanding of the role free fatty acids and fatty acid synthases play in the disease. 
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1.3.4 Use of ambient MS towards the molecular understanding of endometriosis 
The final chapter of my dissertation focuses on the utilization of ambient 
ionization MS imaging towards the increased understanding of a disease that could 
greatly benefit from the advantages afforded by this technology. Endometriosis is a 
gynecological condition in which the endometrial tissue that typically lies the walls of the 
uterus grows in other areas of the abdominal cavity. This condition that affects 
approximately 176 million women worldwide can cause chronic severe pain and 
subfertility, greatly diminishing the quality of life of patients. Unfortunately, despite its 
prevalence and impacts, little is known about the cause of the disease and noninvasive 
biomarkers of the condition have yet to be discovered. MS has been used to analyze 
endometriosis lesions previously, but the heterogeneity of the lesions and the comorbidity 
of endometriosis with other ailments has prevented to detection of reliable biomarkers. 
Chapter 5 outlines the use of DESI-MS imaging for the metabolic analysis of 
endometriosis lesions and healthy endometrium tissue to determine if there are 
differences between these two histologically similar tissue types. The spatial correlation 
of the lipids and metabolites with the histological features of the endometrial glands and 
stroma allowed by MS imaging yielded molecular data specific to these tissue types. The 
molecular data collected with DESI-MS is solely from our cell types of interest, 
facilitating confidence that the metabolic information collected is an accurate 
representation for the tissue. Comparison of the molecular composition of these tissues 
revealed significant differences between these tissues despite them being the exact same 
tissue type. Using the least absolute shrinkage and selector operator statistical method, a 
model utilizing the MS data was created that was capable of distinguishing eutopic and 
ectopic endometrial tissue with 98.8% accuracy on an independent test set. Statistical 
analysis also yielded identification of 34 molecular ions with significantly altered 
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abundances between the two grounds. Alterations in the free fatty acid, 
phosphatidylserine, and small metabolite abundances were observed as the primary 
contributors to the differences between the two classes of tissue. This study illustrates the 
power of DESI-MS imaging as an exploratory tool towards the understanding of disease, 




Chapter 2: Desorption electrospray ionization mass spectrometry 
imaging is dependent on relative humidity1 
2.1 INTRODUCTION 
The field of ambient ionization MS was introduced over a decade ago with the 
development of desorption electrospray ionization (DESI),18 and direct analysis in real 
time (DART)33 techniques, opening opportunities for MS to be used in settings where 
complex sample preparation and in vacuum analysis are not desired. Since then, tens of 
ambient ionization MS techniques have been established and applied in various research 
fields including drug development34, disease analysis23,30,35, plant biology36, forensics37, 
and others. A fundamental feature of ambient ionization MS is an open atmosphere 
analysis with minimal sample preparation requirements.38 In DESI, a spray of charged 
microdroplets is directed towards a sample surface to desorb, ionize, and transfer 
molecules from the sample surface to a mass spectrometer for analysis.18 When DESI-
MS is performed in the imaging mode, two-dimensional maps of the chemical 
constituents are obtained, displaying the intensity and distribution of the ions throughout 
the surface analyzed.39 DESI-MS imaging has been applied to a variety of samples40,41, 
with exciting applications to biological tissue section imaging and disease diagnosis.42 As 
such, the effects of sample handling and experimental protocols on the quality of the data 
obtained from biological tissue sections have been previously investigated.43 
Nevertheless, operation in an ambient environment comes with the cost of potential 
susceptibility to changes in environmental conditions. In particular, relative humidity 
 
1 Adapted with permission from “Feider, C. L.; DeHoog, R. J.; Sans, M.; Zhang, J.; Krieger, A.; Eberlin, L. 
S., DESI Spray Stability in the Negative Ion Mode Is Dependent on Relative Humidity. J. Amer. Soc. Mass 
Spectrom. 2019, 30 (2), 376-380.” Copyright 2019 American Chemical Society. C.L. Feider, R.J. DeHoog, 
M. Sans, J. Zhang, and A. Krieger assited with the collection and analysis of the data presented in this 
chapeter. C.L. Feider, A. Krieger, and L.S. Eberlin prepared and edited the manuscript. All authors revised 
the manuscript.  
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(RH) has been shown to impact ionization stability and efficacy in several MS 
techniques.44,45 For example, the effect of RH on the mass spectra obtained using plasma-
based ambient ionization sources, such as DART and flowing atmospheric pressure 
afterglow (FAPA), has been reported.46,47 Newsome et al. suggested that small variations 
in RH that occur in a laboratory environment can lead to large variations in DART and 
FAPA mass spectra due to altered ion fragmentation during ionization.48 Several studies 
have investigated how variations in RH alter the Taylor cone formation and ionization in 
electrospray ionization (ESI) sources.49,50 Our group has observed substantial variations 
in spray stability during DESI-MS imaging experiments performed in the negative ion 
mode in our laboratory. After many attempts in source optimization followed by a 
systematic investigation of the potential factors leading to instability, we determined RH 
to be a crucial yet often overlooked factor influencing data quality in DESI-MS imaging. 
Here, we describe how RH affects DESI spray stability in the negative ion mode, and 
briefly discuss why this instability due to RH should be avoided in DESI-MS imaging. 
2.2 MATERIALS AND METHODS 
2.2.1 Chemicals 
The Pierce LTQ ESI negative ion calibration solution was used for spray stability 





Illustration 2.1. Visual representation of the decrease in data quality with decreasing RH 
%. 
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2.2.2 Biological tissue samples 
Mouse brain samples were obtained from BioIVT (Hicksville, NY). Samples were 
stored in a −80 °C freezer until sectioned. Tissue samples were sectioned at a thickness of 
16 μm using a CryoStar NX50 cryostat (Thermo Scientific, San Jose, CA). After 
sectioning, the glass slides were stored in a −80 °C freezer. Prior to MS imaging, the 
glass slides were dried for ∼15 min.  
2.2.3 DESI-MS imaging parameters 
A 2D Omni Spray (Prosolia Inc., Indianapolis, IN) coupled to a Q Exactive and 
an LTQ-Orbitrap Elite mass spectrometers (Thermo Scientific, San Jose, CA) was used 
for tissue profiling and imaging. DESI-MS was performed in both the negative and 
positive ion modes from m/z 100–1500 at 60,000 resolving power. The spatial resolution 
of the imaging experiments was 200 μm. The histologically compatible solvent system 
dimethylformamide/acetonitrile (DMF/ACN) 1:1 (v/v) was used for analysis at a flow 
rate of 1.2 μL/min, unless otherwise states, with 5 kV applied to the solvent.21 The N2 
pressure was set to 180 psi. The capillary temperature of the mass spectrometer was set to 
300 °C. Metabolite and lipid species were tentatively identified using high mass accuracy 
measurements, collision-induced dissociation, and high-energy collision-induced 
dissociation tandem MS analyses, performed using the Orbitrap as the mass analyzer of 
the LTQ-Orbitrap Elite mass spectrometer. 
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2.2.4 Monitoring of relative humidity 
RH was monitored using a TP425 Dickson data logger (Addison, IL). Simulation 
of altered RH environments were done by enclosing the DESI imaging stage with the 
Dickson data logger and a cool air humidifier. 
2.3 RESULTS AND DISCUSSION 
2.3.1 Investigation of sporadic DESI-MS imaging data 
The DESI-MS imaging experiments of mouse brain tissue sections described here 
were performed in the negative ion mode from October 2017 to April 2018 using 
optimized experimental parameters.51 During this period, unexpected scan-to-scan 
variability was observed in the total ion current (TIC) chromatograms obtained on 
different days of analysis, as shown in Figure 2.1 for a period of 9 days from February 28 
to March 8. In conjunction with TIC instability, the mass spectra obtained were 
inconsistent from scan-to-scan (Figure 2.2), with atypical relative abundances of 
metabolites and lipids species commonly detected in DESI mass spectra. Under 
optimized experimental conditions, the relative standard deviation (RSD) of the TIC 
obtained when analyzing across a single line of a mouse brain tissue section was 21.3%, 
resulting in chromatograms presenting a smooth pattern. The RSD calculated for the TIC 
under unstable conditions were significantly higher (68.6%), indicating an issue in our 
experiments. Furthermore, we observed that the spray stability often changed day-to-day 
or even hour-to-hour, despite no change in the DESI-MS source or instrument 
parameters. To investigate the potential causes for the inadequate DESI-MS performance, 
we systematically evaluated hardware and experimental conditions including DESI 
source optimization and mass spectrometers. 
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Figure 2.1. TIC plots obtained from a single line scan DESI-MS analysis of mice brain 
tissue sections at various RH levels. 
At RH > 35% (green outline), the TIC is stable and rapidly increasing and decreasing 
when moving on and off the tissue sample, respectively. At RH ~ 35% (yellow outline), 
the TIC begins to destabilize, showing seemingly random fluctuations. At RH < 35% (red 
outline), the TIC plot shows large variations throughout the tissue that are indicative of 




























         
 







         
 
















         




Figure 2.2. Scan-to-scan variability of the DESI mass spectra from a mouse brain tissue 
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To investigate the potential causes for the inadequate DESI-MS performance, we first 
evaluated if hardware issues related to the DESI source or the mass spectrometer used 
were present. A DESI source that was unstable on an LTQ-Orbitrap Elite mass 
spectrometer was transferred to an Orbitrap Q Exactive mass spectrometer in our 
laboratory to determine if TIC instability was related to an issue with the mass 
spectrometer. The instability remained, indicating the issue was not associated to 
instrument conditions or cleanliness. To evaluate if the source instability was caused by 
the DESI sprayer, we tested multiple DESI sprayers, including several lab-built sprayers 
and a commercial DESI sprayer, and still observed instability. To evaluate if source 
optimization and experimental conditions were related to signal instability, we then 
altered the source geometry of the DESI sprayer, the solvent flow rate and composition, 
the gas flow rate, and the applied voltage. The changes in source parameters that partially 
alleviated the TIC instability were decreasing in the voltage applied from 5 kV to 0 kV 
(Figures 2.3 and A.1) or increasing the solvent flow rate from 1.2 µL/min to 5 µL/min 
(Figure 2.4). The use of MeOH:H2O, another very common DESI spray solvent, rather 
than ACN:DMF, actually decreased the stability of the spray (Figure A.2). The voltage 
dependence indicated that the instability observed could be related to the high electric 
field experienced by the charged microdroplets. However, reducing the applied voltage 
also decreased the TIC intensity by approximately one order of magnitude, making it 
challenging to determine whether lower voltage potentials alleviated the instability or 
reduced it due to lower signal intensity (Figure A.3). To investigate the issue further, we 
decoupled the ionization and desorption processes by performing reflective electrospray 
ionization (RESI)52 using a standard calibration solution as the DESI spray solution. The 
instability remained when infusing at 5 kV but was reduced at 0 kV (Figure A.4),  
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suggesting that the ionization process, not desorption, was the major cause of signal 
instability.  
2.3.2 Evaluation of relative humidity on DESI-MS data quality 
This systematic evaluation of DESI and instrument parameters led to the 
hypothesis that the spray instability was related to an external or environmental factor. A 
noteworthy observation was that decreasing the voltage applied from 5 kV to 0 kV 
(Figures 2.3 and A.1) during a single DESI experiment appeared to alleviate spray 
instability, suggesting that the issue could be related to corona discharges occurring at the 
spray tip. Corona discharge is a common phenomenon in both negative and positive ion 
mode ESI, although corona discharge often onsets at higher voltages in the positive ion 
mode (> 5 kV) than in the negative ion mode.53 This hypothesis is also corroborated by 
the alterations observed in the mass spectra, as shown in Figure 2.5A. Typical mass 
spectra acquired from mouse brain tissue sections using optimized DESI-MS conditions 
are commonly reproducible.21,43,54 In the negative ion mode, deprotonated lipid species 
including m/z 834.528 (glycerophosphoserine (PS) 18:0_22:6) and m/z 885.549 
(glycerophosphoinositol (PI) 18:0_20:4) are commonly observed at high relative 
abundances in the gray matter region of the brain, while m/z 888.623 (sulfatide (ST) 
C24:1) is commonly observed at the high relative abundance in the white matter. On the 
other hand, atypical mass spectra obtained during the period of experimental instability 
presented a higher relative abundance of chloride adducts of lipid species, specifically 
ceramide (Cer) d36:1 at m/z 600.513. The increase in chloride adducts suggests that 
electrical discharge may be occurring at the DESI spray tip, as chloride adduct formation 
is more common in plasma-based than spray-based ionization mechanisms.55 Thus, our 
observations suggested that an external factor was contributing to a discharge increase,  
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Figure 2.5. Comparison of DESI-MS imaging data at low and high RH levels.  
(A) Representative mass spectra from the white matter of a mouse brain tissue section at 
high (39%) and low (28%) RH. Each spectrum is an average of 10 scans. (B) 
Representative DESI-MS ion images collected at low and high RH levels. Low humidity 
results in images with erratic ion distributions that are not reflective of the true molecular 
distribution. High humidity results in images that are consistent with what has been 





causing spray instability. Previous work has suggested that the maximum voltage that can 
be applied to an atmospheric pressure ESI source without inducing corona discharge is 
higher in summer months when atmospheric conditions are presumably more humid.45 
Therefore, we explored the possibility that the external factor affecting DESI spray 
stability was the RH in our laboratory.  
Upon investigation of DESI-MS spray stability during times of low (~ 15–30%) 
and high (~ 40–55%) RH, we found a startling difference in the steadiness of the overall 
TIC (Figure 2.1) and the mass spectra (Figure 2.5A) depending on RH. Figure 2b shows 
the DESI-MS imaging results of two serial mouse brain tissue sections analyzed only 20 
hrs apart at low and high RH levels, using the same mass spectrometer and nearly 
identical DESI source conditions and spatial resolution. As expected from the large 
variations in the TIC and mass spectra patterns in low-RH conditions, the DESI ion 
images acquired at low RH conditions were not in agreement with the lipid distributions 
commonly seen in mouse brain tissue, which have been extensively reported in the 
literature using various ionization methods.54,56 At low RH, the intensity of the molecular 
ions spiked sporadically, resulting in spotty ion images and a higher relative intensity of 
the chloride adduct of (Cer) d36:1 at m/z 600.513. An atypical reduction in the relative 
abundance and total intensity for a variety of phospholipid species, including PS 
18:0_22:6 and PI 18:0_20:4, was also observed. Under higher RH levels, smooth TIC as 
well as typical mass spectra and ion spatial distributions were observed in the DESI-MS 
imaging data for the mouse brain tissue, in agreement with what has been extensively 
reported in the literature.39,54  
Further experiments were performed to more confidently determine that RH significantly 
contributes to DESI spray instability. A semi-enclosed DESI-MS chamber connected to a 
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humidifier and a nitrogen gas source was used to control RH levels during DESI-MS 
imaging experiments at constant temperature (T = 23 °C). Figure 2.6 shows the data 
acquired in a DESI-MS experiment within the same mouse brain tissue section, with the 
first TIC chromatogram taken at ~ 60% RH followed by a purge of the humid air with N2 
gas to acquire the second TIC chromatogram at ~ 16% RH. The RSD in TIC of the scans 
acquired at 60% RH was 3.3%, while an RSD of 23.6% was calculated from the data 
collected at 16% RH. Note that these RSD values are lower than those reported when the 
DESI system is not enclosed, suggesting that there is a difference in running these 
experiments in an enclosed system compared to the open environment. However, these 
results still suggest an increase in DESI spray instability due to RH levels. To further 
evaluate the relationship between DESI signal stability and RH, we plotted the RSD 
between TIC values collected at five RH ranges, 10–20%, 20–30%, 30–40%, 40–50%, 
and 50–60%, for the same regions of mouse brain tissue sections (Figure 2.7) using the 
semi-enclosed chamber. These data show that the RSD of the TIC is higher and more 
variable at lower RH than at higher RH levels, and the difference was statistically 
significant between the lowest and highest RH ranges investigated (p < 0.05). Similar 
experiments were conducted in the positive ion mode and as previously noted RH did not 
appear to have a significant impact on DESI spray stability or the acquired spectra 
(Figure A.5). Note that further work is needed to evaluate the effects of even higher RH 
(> 70%) on DESI spray stability, as this range could not be achieved and thus 





Figure 2.6. TIC chromatograms at stable RH conditions (>40%) and unstable RH 
conditions (<30%).  
From times 1.5-3.0 min, a semi-enclosed chamber containing the DESI source as purged 




Figure 2.7. RH% vs. RSD% of the TIC at five RH% ranges. 
10– 20% (n = 4), 20–30% (n = 6), 30–40% (n = 9), 40–50% (n = 4), and 50–60% (n = 
10). Both the average RSD and the RSD variance for the 10–20% and 50–60% ranges 
were significantly different from each other (p < 0.05), suggesting there are observable 
and noteworthy differences in the stability of DESI depending on RH%. An average of 
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2.4 CONCLUSIONS 
We have performed a study to evaluate the causes of signal instability in 
optimized DESI-MS experiments and have determined that DESI spray stability is 
dependent on RH levels in the negative ion mode under the experimental conditions 
evaluated. Under low-humidity conditions (~ 15–30%), negative ion mode DESI mass 
spectra were prone to spray artifacts resulting in atypical ion abundances and inaccurate 
spatial distributions, while stable and typical mass spectra were obtained in RH levels of 
35–60%. Our data suggest that signal instability could be due to corona discharges 
occurring at the DESI spray under low-humidity conditions, although this hypothesis is 
not fully confirmed. As a primary goal of DESI-MS imaging is to obtain reproducible 
and spatially accurate mass spectral data from tissue sections, the reduction in data 
quality associated with low-RH conditions is noteworthy. Further, as DESI-MS imaging 
is often used to qualitatively evaluate trends in mass spectra patterns that allow disease 
diagnosis and statistical classification,42 attention to this matter is important. Special 
consideration should be given in winter months when RH is typically lower, which was 
the case in our study, as buildings may not have advanced humidity control infrastructure 
to adjust for drastic local weather fluctuations. Thus, based on the data presented here, we 
suggest that RH conditions should be monitored and maintained at levels of 35–60% RH 




Chapter 3: Ambient ionization and field asymmetric ion mobility mass 
spectrometry for enhanced imaging of multiply charged molecular ions 
in biological tissues2 
3.1 INTRODUCTION 
Mass spectrometry (MS) imaging provides the outstanding ability of probing the 
spatial distribution of molecules in a sample surface with high specificity and 
sensitivity.57-59 In particular, ambient ionization MS imaging techniques have 
revolutionized the means by which spatial and molecular information is obtained from 
biological samples by enabling in situ, real time analysis of tissue samples with minimal 
pretreatment.38,60 Desorption electrospray ionization (DESI) is the most commonly used 
solvent-based ambient ionization MS technique to image and characterize lipids and 
metabolites in biological tissue samples.18,39 DESI has been increasingly applied for 
cancer diagnosis with the perspective of clinical use.42 In addition to DESI, other solvent-
based ambient ionization techniques have been used to analyze biological tissue samples, 
including liquid microjunction surface sampling probe (LMJ-SSP)61 and nanoDESI.62,63 
Despite providing a wealth of chemical and spatial information, inherent challenges of 
sample complexity using direct analysis by MS imaging have prevented comprehensive 
detection and characterization of molecular species.61,63 Naturally occurring lipids, for 
example, present enormous diversity of molecular structures and are observed over a 
relatively narrow mass-to-charge (m/z) range as molecular ions. Isobaric interferences in 
the mass spectrum complicate tandem MS analysis for structural characterization and 
 
2 Adapted with permission from “Feider, C. L.; Elizondo, N.; Eberlin, L. S., Ambient Ionization and 
FAIMS Mass Spectrometry for Enhanced Imaging of Multiply Charged Molecular Ions in Biological 
Tissues. Analytical Chemistry 2016, 88 (23), 11533-11541” Copyright 2016 American Chemical Society. 
C.L. Feider contributed to the collection and analysis of data and preparation of the manuscript. N. 
Elizondo assited in the collection of data. L.S. Eberlin assited in the preparation and editing of the 
manuscript. All authors revised the manuscript. 
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obscures visualization of an ion’s spatial distribution,64 an issue that has been previously 
addressed through MS/MS imaging.65 Lipids present in high concentration in biological 
tissues may also suppress the detection of other lipids at lower abundances.66 Protein 
imaging directly from biological samples is also an ongoing analytical challenge for 
ambient ionization techniques, although recent progress has been made.67 New 
approaches that integrate several analytical strategies are needed for improved imaging 
and characterization of molecules within biological tissue samples.68,69 Ion mobility has 
been increasingly applied to overcome issues in complex sample analysis by MS.70-72 In 
particular, high-field asymmetric waveform ion mobility spectrometry (FAIMS), or 
differential mobility separation, separates gas phase ions at atmospheric pressure on the 
basis of differences in their mobilities in electric fields prior to MS analysis.73 A high-
frequency, asymmetric waveform is employed by alternating low and high electric fields 
perpendicular to the path through which the ions travel.74 This waveform, called the 
dispersion field (DF), causes the ions to be displaced from their initial trajectories, collide 
with the electrode walls, and be dissipated. However, a second, smaller DC voltage can 
be applied between the two electrode plates, creating a low-energy electric field that is 
superimposed on the DF. This compensation field (CF) counteracts the ion drift caused 
by the DF, allowing ions with specific mobilities to be transmitted for mass analysis. The 
high-speed gas phase separation provided by FAIMS has been shown to reduce chemical 
noise and to improve signal-to-noise ratios (S/N), sensitivity, and dynamic range.73 By 
optimizing the DF and CF, semi-selective transmission of subsets of ions or classes of 
molecules can be achieved. The filtering capability of FAIMS allows only subsets of ions 
to enter and fill the mass analyzer, resulting in higher sensitivity in their detection. 
Several groups have explored the use of FAIMS, as well as other ion mobility techniques, 
for MSI applications.75-79 A lab-built DMS cell integrated with a DESI platform was used 
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to image glycerophosphocholines (PC) in a mouse brain tissue, resulting in decreased 
chemical noise, as well as improved S/N and image contrast.80 More recently, liquid 
extraction surface analysis (LESA) was integrated with the FAIMS device we applied in 
our study to image proteins in mouse brain and liver tissue samples.81,82 Using the 
integrated LESA-FAIMS approach, 26 protein species in mouse brain and 29 protein 
species in mouse liver undetectable through LESA alone were observed.82 Here, we 
report an analytical approach coupling DESI or LMJ-SSP with FAIMS to image and 
characterize lipids and proteins from biological tissue sections. In our study, we 
integrated and optimized a chip-based, high-speed ultraFAIMS device with DESI-
MS/LMJ-SSP-MS and a high mass resolution mass spectrometer to image and 
characterize singly charged metabolites, singly- and doubly charged 
glycerophospholipids (GP) and glycosphingolipids, and multiply charged proteins in rat 
brain, human thyroid, and human ovarian cancer tissues. 2D-FAIMS sweep experiments 
were performed in tandem with DESI-MS imaging using a spot-by-spot approach to 
explore separation voltages for specific molecular classes of lipids and metabolites in a 
rat brain tissue section. Static, optimized FAIMS conditions were then used for doubly 
charged CL and gangliosides with no increase in analysis time. Multiply charged protein 
ions were imaged in biological tissues using LMJ-SSP-FAIMS with enhanced analytical 
performance. Using this approach, we show the first example of global protein imaging 
in human cancerous tissue by ambient ionization MS imaging. Our results indicate that 
integration of FAIMS with DESI or LMJ-SSP is valuable for imaging selected molecular 
classes in biological tissues. 
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Illustration 3.1. Scheme of the integration of LMJ-SSP and DESI integrated with an 











3.2 MATERIALS AND METHODS 
3.2.1 Chemicals 
18:1 glycerophosphoinositol (PI), 18:1 glycerophosphoserine (PS), 18:1 
glycerophosphoethanolamine (PE), 18:1 glycerophosphoglycerol (PG), 18:1 
glycerophosphatidic acid (PA), 18:1 cardiolipin (CL), and a total ganglioside extract were 
purchased from Avanti Polar Lipids (Alabaster, AL). Fatty acids (FA) including oleic 
acid, lignoceric acid, and arachidonic acid, as well as metabolites n-acetylaspartic acid 
(NAA) and 2-hydroxyglutarate were purchased from Sigma-Aldrich (St. Louis, MO). 
Standards were dissolved in chloroform/methanol (CHCl3/MeOH) 1:1 (v/v) at a 
concentration of 10 μg/mL. A ubiquitin standard (Sigma-Aldrich, St. Louis, MO) was 
dissolved in acetonitrile/water (ACN/H2O) 60:40 (v/v) with 0.1% formic acid at 1 μg/mL. 
Direct electrospray ionization (ESI) infusion of the standards was performed at a flow 
rate of 5 μL/min. 
3.2.2 Biological tissue samples 
Rat brain samples were obtained from BioreclamationIVT (Hicksville, NY). 
Banked frozen human tissue samples including human thyroid oncocytic tumor, ovarian 
cancer, and normal ovarian tissues were obtained from Cooperative Human Tissue 
Network (CHTN) under approved IRB protocol. Samples were stored in a −80 °C freezer 
until sectioned. Tissue samples were sectioned at a thickness of 16 μm using a CryoStar 
NX50 cryostat (Thermo Scientific, San Jose, CA). After sectioning, the glass slides were 
stored in a −80 °C freezer. Prior to MSI, the glass slides were dried for ∼15 min. For 
protein analysis, sections were washed in ethanol for 10 s, followed by a wash in 
chloroform for 10 s to remove excess lipids. 
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3.2.3 FAIMS parameters 
An ultraFAIMS device (Owlstone Ltd., Cambridge, UK) using an ND chip 
(Owlstone), was used for all experiments performed. The ND chip has a trench length of 
97.0 μm, a gap width of 101.51 μm, and a chip thickness of 700 μm. The chip-region 
temperature was set to 90 °C. At this temperature, the DF can be set to any value from 0 
to 280.98 Townsends (Td) and the CF from −14.84 to 14.84 Td. 
3.2.4 DESI-MS imaging parameters 
A 2D Omni Spray (Prosolia Inc., Indianapolis, IN) coupled to a Q Exactive mass 
spectrometer (Thermo Scientific, San Jose, CA) was used for tissue profiling and 
imaging. An unheated extended transfer tube of 5 in. with an inner diameter of 0.067 in. 
was lab-built to fit the FAIMS platform. DESI-MSI was performed in the negative ion 
mode from m/z 100–1500, using the Q Exactive mass spectrometer which allows for high 
mass accuracy (<5 ppm mass error) and high mass resolution (70,000 resolving power at 
m/z 200) measurements. The spatial resolution of the imaging experiments was 200 μm. 
The histologically compatible solvent system dimethylformamide/acetonitrile 
(DMF/ACN) 1:1 (v/v) was used for analysis at a flow rate of 1.2 μL/min with 5 kV 
applied to the solvent.21 The N2 pressure was set to 180 psi. The capillary temperature of 
the mass spectrometer was set to 300 °C. 
3.2.5 LMJ-SSP-MS imaging parameters 
An LMJ-SSP system, the Flowprobe (Prosolia Inc. Indianapolis, IN), coupled to a 
Q Exactive mass spectrometer (Thermo Scientific, San Jose, CA) was used for tissue 
profiling and imaging. LMJ-SSP-MS imaging was performed in the positive ion mode 
from m/z 250–2000, using the hybrid Quadrupole-Orbitrap mass spectrometer. The 
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spatial resolution of the imaging experiments was ∼630 μm. The solvent system of 
acetonitrile/water (ACN/H2O) 60:40 (v/v) with 0.1% formic acid was used for analysis at 
a flow rate of 40 μL/min, as suggested by the manufacturer (10–100 μL/min). The N2 
pressure was between 30 and 70 psi and was adjusted manually when necessary to 
maintain the liquid microjunction throughout experiments. Leaking of the solvent from 
the probe is avoided through alterations in pressure applied to the ESI source but can 
occur during operation. The voltage applied to the solvent within the ESI nozzle was 4 
kV, and the capillary temperature of the mass spectrometer was 300 °C. 
3.2.6 Tissue staining and histological evaluation 
The same tissue sections analyzed by DESI-MS imaging and adjacent sections 
analyzed by LMJ-SSP-MS imaging were stained using standard H&E staining protocol. 
Pathologic evaluation was performed using light microscopy. 
3.2.7 Lipid and protein identification 
Lipid species were identified using high mass accuracy measurements and higher-
energy collision induced dissociation (HCD) tandem MS analysis, performed on the Q 
Exactive at 70,000 resolving power (m/z 200). Lipid fragmentation patterns were 
compared to literature reports and used in conjunction with data from Lipidmaps database 
(www.lipidmaps.org) for identification. For protein identification, mass spectra from 
sequential profiling experiments with and without the FAIMS separation were obtained. 
The data was deconvoluted using the Xtract function within Xcalibur software using a 
S/N threshold of 3 to obtain monoisotopic masses of protein species detected during 
experiments. Protein species were analyzed by top-down collision induced dissociation 
(CID) tandem MS, performed on a hybrid LTQ-Orbitrap Elite mass spectrometer 
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(Thermo Scientific, San Jose, CA) at 120,000 resolving power at m/z 200. Protein 
fragmentation patterns were input into ProSight Lite software 
(http://prosightlite.northwestern.edu/) and compared with protein amino acid sequences 
that have been previously observed within the tissue types analyzed. Protein amino acid 
sequences were obtained from the UniProt database 
3.2.8 2D imaging data analysis 
Xcalibur RAW files were converted into images using FireFly data conversion 
software (Prosolia, Inc. Indianapolis, IN) and then uploaded into the open source imaging 
software packages BioMap (Novartis) or MSiReader83 for visualization. The interpolate 
function within BioMap was used to smooth the pixels within the images. All images are 
normalized to the maximum ion intensity within all the spectra (all pixels) used to create 
the image. 
3.3 RESULTS AND DISCUSSION 
3.3.1 Optimization of FAIMS for separation of lipids and metabolites 
To evaluate FAIMS separation voltages for lipids and metabolites, a synthetic 
mixture of standards was prepared and analyzed using ESI and DESI in the negative ion 
mode. The mixture of lipids contained species from the main classes of GP commonly 
detected from biological tissues in the negative ion mode including singly charged PI, PS, 
PE, PG, and PA, doubly charged CL and gangliosides, three common FA (oleic, 
lignoceric, and arachidonic), and two representative metabolites, NAA and 2-
hydroxyglutarate. For ESI experiments, the synthetic mixture was directly infused while 
a 2D FAIMS field sweep was performed in which the DF was stepped in 10 Td 
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increments from 150 to 280 Td with a CV sweep from −1 to +4 Td occurring at every DF 
value. Increasing DF causes an increase in separation efficiency while decreasing total 
ion current. Thus, an optimal DF was chosen as the field at which lipids and metabolites 
were most clearly separated in the ion chromatogram without detrimental loss of total ion 
current. At this selected DF value, an optimal CF for each species was chosen as the 
voltage at which the specific ion had a maximum total intensity. ESI experiments yielded 
an optimal DF of 220 Td for the highest transmittance and separation of lipids and small 
metabolites by FAIMS. At this DF, optimal CFs were determined for small metabolites 
(CF = −0.10 Td), singly charged GP (CF = 0.99 Td), singly charged FA (CF = 1.17 Td), 
doubly charged gangliosides (CF = 1.80 Td), doubly charged CL (CF = 2.20 Td), and 
triply charged gangliosides (CF = 2.71 Td), as shown in Figure 3.1. A trend in optimized 
CF values was observed, in which higher CF values were ideal for transmission of larger, 
multiply charged ions and lower CF values were more suitable for the transmission of 
smaller, singly charged ions. Note that while different optimized CF values allowed 
separation of doubly charged CL and gangliosides from singly charged GP species, 
separation of different subclasses of singly charged GP was not clearly observed. DESI-
FAIMS optimization experiments performed on the synthetic lipid and metabolite 
mixture yielded similar optimized CF values for the species of interest at DF of 220 Td. 
For both ESI and DESI, a drop in total ion current of 1 order of magnitude or more was 
observed with FAIMS separation for all experiments performed. Planar FAIMS devices 
are known to cause an exponential decrease in ion transmission with increasing residence 
time within the device in order to achieve higher separation resolving power.84 Thus, 
despite the short residence time associated with this chip-based device, this method is not 
immune to this decrease in total ion transmission. Nevertheless, further decrease of noise 
leads to an overall increase in the S/N for selected molecular ions.84 Optimization of the  
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Figure 3.1. Optimization of FAIMS separation parameters for multiple lipid and 
metabolite classes using direct infusion. 
 (A) Chromatogram of a compensation field sweep (-1-4 Td) at a dispersion field of 220 
Td, in which numbers annotating the peak field values for the transmission of different 
molecular classes of interest: metabolites, fatty acids, phospholipids, and doubly-charged 
species, i.e. cardiolipin (B) Spectra corresponding to the compensation field at which 





DESI-FAIMS system was also performed for imaging lipids and metabolites from a 
tissue sample in the negative ion mode. A spot-by-spot DESI analysis of a rat brain tissue 
section was performed using a methodology similar to the one employed for ESI. At a 
spatial resolution (step size) of 200 μm, the DF was kept constant at the optimized 220 
Td while a 1D FAIMS sweep (CF= −1 to 3 Td) was performed (Figure 3.2A). A total of 
eight mass spectra, each corresponding to a 0.5 Td CF increment, were acquired at each 
spot. Using this approach, a total of 6 s of analysis time was required for each spot 
(pixel). The spectra for each field were extracted and compiled into 2D ion images, 
yielding eight sets of 2D DESI-MS images at specific DF and CF values that highlight 
different molecular classes transmitted at the optimized voltages (Figure 3.2B). Although 
time-consuming, this DESI-FAIMS-MS imaging experiment allowed optimization of 
separation voltages for metabolites, FA, singly charged GP, doubly charged CL, and 
gangliosides, directly from a tissue sample. For example, preferential transmission and 
highest relative abundances of metabolites were observed at CF = 0 – 0.5 Td. At these 
parameters, clear spatial distribution of NAA, recently described as a glioma 
oncometabolite,29 was observed mainly in the brain cortex. In contrast, doubly charged 
species (CL and gangliosides), which are difficult to image within complex biological 
tissue samples due to their low abundances, are nearly exclusively observed at CF= 2 – 
2.5 Td. We note that a slight drop in signal intensity was observed with analysis time in 
each spot (Figure B.1), which could account for lower image quality for the species 
observed at higher CF values. At CF range 2.5–3 Td, little to no ion transmission through 
the FAIMS device was observed. The same optimal ion transmission voltages were 




Figure 3.2. 2D-FAIMS, spot-by-spot DESI-MS imaging of a rat brain tissue section.  
(A) Schematic of the 2D FAIMS sweep experiment used to create multiple sets of DESI-
MS ion images at varied CF values in one tissue section. Each 200 μm spot on the tissue 
was analyzed for 6 s for a total of 8 MS acquisitions, in which a FAIMS sweep occurred, 
allowing MS acquisition correlated to different CF ranges. (B) DESI-FAIMS-MS ion 
images for a rat brain tissue section for 6 representative lipid and metabolite species, each 
acquired at DF = 220 Td and a different CF range, thus highlighting the increased 
transmission of different molecular species at each CF value. Small metabolites transmit 
at the lowest CF (−1 to +0.5 Td), followed by FA and singly charged complex lipids at 
midrange CF (0.5–1.5 Td), and doubly charged CL and gangliosides at the high-range CF 
(1.5–2.5 Td).  
   
                         
                      
                          
  
                                                     
                                
          
              
   
       
          
   
       
         
   
       
   
       
             
   
       
           
        
     
     
     
     
     
      























            
        
   
       
     
                                   




3.3.2 DESI-FAIMS semi-selective imaging of cardiolipins and gangliosides in rat 
brain sections 
We further explored the DESI-FAIMS methodology for optimized imaging of doubly 
charged CL and gangliosides from biological tissue samples. CL are a complex class of 
GP that exist almost exclusively within the inner mitochondrial membrane of cells. These 
unique lipids are important structural and functional components of both normal and 
diseased tissues, and have been increasingly explored in a variety of pathologies.85-87 We 
first performed DESI-FAIMS-MSI of doubly charged CL within rat brain tissue sections 
at the optimized FAIMS parameters in the negative ion mode. In this static FAIMS 
approach, both the DF and CF remain constant throughout the entire tissue imaging 
experiment at the optimized settings (DF = 220 Td, CF = 2.20 Td). Thus, DESI-MSI was 
operated in the usual rastering mode (0.5 s/pixel), without increase of analysis time, and 
with a spatial resolution of 200 μm. An evident increase in the S/N of CL species in 
comparison to other GP species was observed in the mass spectra obtained using DESI-
FAIMS-MS imaging when compared to DESI-MS imaging alone (Figure 3.3). For 
example, using DESI-FAIMS-MS imaging, an increase in the S/N from 116 to 203 for an 
average of 50 spectra was observed for the most abundant CL species (m/z 749.495, CL 
(20:4_20:4_20:4_18:1), mass error of −0.93 ppm), with minimal change in absolute 
signal intensity (from 1.78 × 104 to 1.98 × 104), resulting in images that highlight the CL 
species over other GP within the tissue sample (Figures 3.3C and 3.4). MS fragmentation 
patterns for low abundance CL were unclear, tentative identification was based on 
accurate mass measurements alone. Overall, about 50% increase in the S/N was observed 
for all CL species detected with the DESI-FAIMS-MS imaging approach. Most 
importantly, an increase in the number of detectable CL species was observed with the 




Figure 3.3. Static DESI-FAIMS-MSI of CL in rat brain tissue.  
(A) Representative negative ion mode DESI mass spectra acquired without and with 
FAIMS in the m/z 700–800 range at the optimized doubly charged CL parameters (DF = 
220 Td, CF = 2.20 Td), showing a clear increase in the relative abundance of CL species. 
Without FAIMS and with FAIMS spectra are averages of one DESI line scan, consisting 
of 68 and 66 scans, respectively. (B) Chart of CL species detected with DESI alone and 
the DESI-FAIMS integrated approach. (C) 2D DESI-FAIMS ion images for selected CL 










                  
















       
       
       
       
       
       
       
               
       
       
        
       
        
       
        
       
       
       
         
       
       
             
          
       
         
          
        
          
















   
      
      
          
       
           





Figure 3.4. DESI-MS and DESI-FAIMS-MS ion images of rat brain tissue for five 
representative CL species compared to another representative lipid species. 
There is an increase in relative abundance of CLs associated with FAIMS selective 
imaging and a significant decrease in the signal intensity from singly charged lipid 























of 1.00 ppm, was only observed by DESI-FAIMS-MS imaging and undetected with 
DESI-MS imaging alone. In total, 71 CL species were detected and identified using 
DESI-FAIMS-MS imaging, compared to 48 CL species detected when using DESI-MS 
imaging alone, as summarized in Table 3.1. Acyl chain composition, but not their sn 
position, was tentatively assigned based on tandem MS patterns, an example of which is 
shown in Figure B.2. When tandem MS fragmentation patterns for low abundance CL 
were unclear, tentative identification was based on accurate mass measurements alone. 
Imaging of doubly charged gangliosides was performed using serial rat brain 
tissue sections at optimized FAIMS parameters (DF = 220 Td, CF = 1.8 Td) in the 
negative ion mode. Gangliosides are a subclass of glycosphingolipids which are most 
abundant within the nervous system. Gangliosides have important cellular functions, such 
as cell signaling and calcium homeostasis, and have been associated with multiple 
diseases including Alzheimer’s and Tay-Sachs diseases.88,89 DESI-FAIMS-MS imaging 
yielded an increased relative abundance and S/N of gangliosides compared to DESI-MS 
imaging alone. For example, the S/N of the most abundant ganglioside species detected, 
identified as trisialotetrahexosylganglioside at m/z 1063.530 (GT1 d36:1), doubled using 
FAIMS. Out of the 21 doubly charged ganglioside species detected by DESI-FAIMS-MS 
imaging, 7 were undetectable by traditional DESI-MS imaging (Table 3.2). Ganglioside 
species were identified by tandem MS experiments, an example of which is shown in 
Figure B.3. Gangliosides present at low relative abundances were tentatively identified 
by accurate mass alone. Note that while FAIMS allowed improved detection of triply 
charged gangliosides at CF = 2.71 Td using a standard lipid mixture, this charge state was 
not observed in biological tissues by DESI-FAIMS or DESI alone due to low abundance 
of gangliosides at this charge state under our experimental conditions. 
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Table 3.1. Representative CL species detected during DESI-MSI and FAIMS-DESI-MS 
imaging analysis of rat brain tissue. 
 







697.4654 697.4626 CL 68:6 -4.01 C77H138O17P2 
698.4718 698.4704 CL 68:5 -2.00 C77H140O17P2 
699.4803 699.4783 CL 68:4 -2.86 C77H142O17P2 
700.4885 700.4861 CL 68:3 -3.43 C77H144O17P2 
709.4647 709.4626 CL 70:8 -2.96 C79H138O17P2 
710.4727 710.4705 CL 70:7 -3.10 C79H140O17P2 
711.4796 711.4783 CL 70:6 -1.83 C79H142O17P2 
712.4876 712.4861 CL 70:5 -2.11 C79H144O17P2 
713.4955 713.4939 CL 70:4 -2.24 C79H146O17P2 
714.5012 714.5018 CL 70:3 0.84 C79H148O17P2 
715.5065 715.5096 CL 70:2 4.33 C79H150O17P2 
717.4803 717.4783 CL 71:7 -2.79 C80H142O17P2 
718.489 718.4861 CL 71:6 -4.04 C80H144O17P2 
719.4963 719.4940 CL 71:5 -3.20 C80H146O17P2 
720.5048 720.5018 CL 71:4 -4.16 C80H148O17P2 
721.4654 721.4626 CL 72:8 -3.88 C81H138O17P2 
722.4727 722.4705 CL 72:7 -3.05 C81H140O17P2 
723.4806 723.4783 CL 72:6 -3.18 C81H142O17P2 
724.4878 724.4861 CL 72:5 -2.35 C81H144O17P2 
725.4943 725.4939 CL 72:4 -0.55 C81H146O17P2 
726.5029 726.5018 CL 72:3 -1.51 C81H148O17P2 
727.5103 727.5096 CL 72:2 -0.96 C81H150O17P2 
728.516 728.5174 CL 72:1 1.92 C81H152O17P2 
729.4827 729.4783 CL 73:9 -6.03 C82H142O17P2 
729.5254 729.5252 CL 72:0 -0.27 C81H154O17P2 
730.4873 730.4861 CL 73:8 -1.64 C82H144O17P2 
731.4947 731.4939 CL 73:7 -1.09 C82H146O17P2 
733.4658 733.4626 CL 74:12 -4.36 C83H138O17P2 
734.4726 734.4705 CL 74:11 -2.86 C83H140O17P2 
735.4803 735.4783 CL 74:10 -2.72 C83H142O17P2 
736.4874 736.4861 CL 74:9 -1.77 C83H144O17P2 
737.4956 737.4939 CL 74:8 -2.31 C83H146O17P2 
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738.5032 738.5018 CL 74:7 -1.90 C83H148O17P2 
739.5087 739.5096 CL 74:6 1.22 C83H150O17P2 
740.5154 740.5174 CL 74:5 2.70 C83H152O17P2 
741.5216 741.5252 CL 74:4 4.85 C83H154O17P2 
742.4877 742.4861 CL 75:10 -2.15 C84H144O17P2 
746.4734 746.4705 CL 76:13 -3.88 C85H140O17P2 
747.4812 747.4783 CL 76:12 -3.88 C85H142O17P2 
748.4878 748.4861 CL 76:11 -2.27 C85H144O17P2 
749.4952 749.4939 CL 76:10 -1.73 C85H146O17P2 
750.5020 750.5017 CL 76:9 -0.40 C85H148O17P2 
751.5093 751.5096 CL 76:8 0.40 C85H150O17P2 
752.5164 752.5174 CL 76:7 1.33 C85H152O17P2 
753.5249 753.5252 CL 76:6 0.40 C85H154O17P2 
754.4879 754.4861 CL 77:9 -2.39 C86H144O17P2 
755.4946 755.4939 CL 77:8 -0.93 C86H146O17P2 
758.4722 758.4705 CL 78:15 -2.24 C87H140O17P2 
759.4800 759.4783 CL 78:14 -2.24 C87H142O17P2 
760.4874 760.4861 CL 78:13 -1.71 C87H144O17P2 
761.4949 761.4939 CL 78:12 -1.31 C87H146O17P2 
762.5031 762.5018 CL 78:11 -1.70 C87H148O17P2 
763.5108 763.5096 CL 78:10 -1.57 C87H150O17P2 
764.5217 764.5174 CL 78:9 -5.62 C87H152O17P2 
765.5277 765.5252 CL 78:8 -3.27 C87H154O17P2 
770.4733 770.4705 CL 80:17 -3.63 C89H140O17P2 
771.4806 771.4783 CL 80:16 -2.98 C89H142O17P2 
772.4886 772.4861 CL 80:15 -3.24 C89H144O17P2 
773.4950 773.4939 CL 80:14 -1.42 C89H146O17P2 
774.5007 774.5017 CL 80:13 1.29 C89H148O17P2 
775.5109 775.5096 CL 80:12 -1.68 C89H150O17P2 
776.5178 776.5174 CL 80:11 -0.52 C89H152O17P2 
777.5264 777.5252 CL 80:10 -1.54 C89H154O17P2 
783.4798 783.4783 CL 82:18 -1.91 C91H142O17P2 
784.4882 784.4861 CL 82:17 -2.68 C91H144O17P2 
785.4935 785.4939 CL 82:16 0.51 C91H146O17P2 
786.4991 786.5018 CL 82:15 3.43 C91H148O17P2 
Table 3.1. (cont.) 
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795.4814 795.4783 CL 84:20 -3.90 C93H142O17P2 
796.4873 796.4861 CL 84:19 -1.51 C93H144O17P2 
797.4937 797.4939 CL 84:18 0.25 C93H146O17P2 
798.4994 798.5018 CL 84:17 3.01 C93H148O17P2 
 
[a] Red text denotes species that were only detectable with the addition of FAIMS with 
















Table 3.1. (cont.) 
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Table 3.2. Representative ganglioside species detected during DESI-MS imaging and 
FAIMS-DESI-MS imaging analysis of rat brain tissue and identified using 








917.4798 917.4782 GD1 d36:2 [M-2H]2- -1.74 C84H148N4O39 
918.4832 918.4860 GD1 d36:1 [M-2H]2- 3.05 C84H150N4O39 
919.4886 919.4939 GD1 d36:1 [M-2H]2- 5.76 C84H152N4O39 
931.4957 931.4939 GD1 d38:1 [M-2H]2- -1.93 C86H152N4O39 
932.4993 932.5017 GD1 d38:0 [M-2H]2- 2.57 C86H154N4O39 
952.5009 952.4991 Acetylated GD1b d38:1 [M-2H]2- -1.89 C88H154N4O40 
1063.0278 1063.0259 GT1 d36:1 [M-2H]2- -1.79 C95H165N5O47 
1064.0313 1064.0338 GT1 d36:0 [M-2H]2- 2.35 C95H167N5O47 
1073.0093 1073.0103 GT1 d38:4 [M-2H]2- 0.93 C97H161N5O47 
1074.0175 1074.0181 GT1 d38:3 [M-2H]2- 0.56 C97H163N5O47 
1075.0205 1075.0259 GT1 d38:2 [M-2H]2- 5.02 C97H165N5O47 
1077.0433 1077.0416 GT1 d38:1 [M-2H]2- -1.58 C97H169N5O47 
1078.0454 1078.0494 GT1 d38:0 [M-2H]2- 3.71 C97H171N5O47 
1082.0055 1082.0039 




GT1 d36:0- Potassium adduct [M-
3H+K]2- 
-4.71 C95H167N5O47 
1084.0323 1084.0312 Acetylated GT1 d36:1 [M-2H]2- -1.01 C97H167N5O48 
1085.0360 1085.0390 Acetylated GT1 d36:0 [M-2H]2- 2.76 C97H169N5O48 
1096.0210 1096.0195 




GT1 d38:0- Potassium adduct [M-
3H+K]2- 
-1.91 C97H171N5O47 
1098.0490 1098.0466 Acetylated GT1 d38:1 [M-2H]2- -2.19 C99H171N5O48 
1099.0496 1099.0547 Acetylated GT1 d38:0 [M-2H]2- 4.64 C99H173N5O48 
  
[a] Red text denotes species that were only detectable with the addition of FAIMS with 
DESI-MS imaging 
[b] (X:Y) denotes the total number of carbons and doubles bonds within the steric acid and 
sphingosine chains 
[c] Calculated based on the exact monoisotopic m/z of the deprotonated molecular ion. 
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3.3.3 DESI-FAIMS-MS imaging of cardiolipins in human oncocytic thyroid tumors 
We have recently described a diverse group of CL as molecular markers of 
oncocytic thyroid tumors, including oxidized CL, adducts of CL and PC, and 
monolysocardiolipins.27 However, many of the diagnostic CL are detected at low relative 
abundances and within close m/z values to other interfering GP, which complicates ion 
isolation for tandem MS experiments, obscures visualization of their 2D distribution, and 
adds complexity to data analysis. Thus, we applied the integrated DESI-FAIMS-MS 
imaging approach to improve imaging of CL in oncocytic thyroid tumors. Two serial 
sections from an oncocytic thyroid tumor were subjected to DESI-MSI under identical 
conditions in the negative ion mode, one with static mode FAIMS at the optimized CL 
voltages, and one without FAIMS separation. As shown in Figure 3.5A, DESI-FAIMS-
MS imaging allowed enhanced detection of CLs within the oncocytic thyroid tumor 
tissue section with reduced interference from other GP in the m/z 700–800 range. For 
example, using DESI-MS imaging alone, PE(O-38:5) at m/z 750.545 had a signal 
intensity 4 times that of the doubly charged CL(76:9) at m/z 750.502. When FAIMS is 
applied, CL(76:9) had a signal intensity double that of PE(O-38:5), which facilitates ion 
isolation, fragmentation, identification, and visualization of its 2D distribution. DESI-
FAIMS-MS imaging revealed high relative abundance of CL within the entire thyroid 
tissue section, as shown in Figure 3.5B for m/z 723.479, m/z 737.494, and m/z 747.473 
identified as CL(18:2_18:2_18:2_18:2 and/or 20:4_18:2_18:2_16:0), 
CL(20:4_18:2_18:1_18:1, 20:3_18:2_18:2_18:1, 20:2_18:2_18:2_18:2) and 
CL(22:6_20:4_18:2_16:0), respectively. These results indicate the presence of oncocytic 
thyroid tumor in the entire tissue section, which was confirmed by histopathologic 




Figure 3.5. Static DESI-FAIMS-MS imaging of CLs in an oncocytic thyroid tumor tissue.  
(A) Representative negative ion mode DESI mass spectra acquired without and with 
FAIMS in the complex lipid region (m/z 700–900) at the optimized doubly charged CL 
parameters (DF = 220 Td, CF = 2.20 Td). Zoom in show spectra from m/z 750–752. 
Without FAIMS and with FAIMS spectra are averages of a DESI line scan, consisting of 
57 and 54 scans, respectively. (B) DESI-FAIMS-MS ion images and optical images of 
the H&E stained oncocytic thyroid tumor sections for three CL species, m/z 723.479, m/z 
737.494, and m/z 747.473, showing high relative intensities of CL, a feature of oncocytic 
tumors (spatial resolution of 200 μm).  
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3.3.4 LMJ-SSP-FAIMS-MS imaging of proteins in rat brain tissue sections 
We next pursued the integration of LMJ-SSP and FAIMS for biological tissue 
imaging. LMJ-SSP provides similar molecular information as DESI from biological 
tissues with higher sensitivity yet lower spatial resolution and image quality, as limited 
by the probe tip diameter (∼630 μm).90 Metabolite and lipid optimization experiments 
performed using LMJ-SSP-FAIMS in the negative ion mode yielded similar results to 
those obtained by DESI-FAIMS. Yet, we found that positive ion mode LMJ-SSP-FAIMS 
allowed obvious improvements for imaging multiply charged protein species from 
biological tissue samples. Thus, we focused our efforts on evaluating and optimizing 
LMJ-SSP-FAIMS for protein imaging. Voltage optimization was performed for mid-
mass range proteins (4–12 kDa) through LMJ-SSP-FAIMS profiling of a rat brain tissue 
section while conducting a 2D-FAIMS sweep from DF 230–280 Td and CF 0–4 Td. 
Ubiquitin, a well-known protein with a molecular weight of 8.5 kDa, was used for 
optimization. The highest abundance of its 10+ charge state at m/z 857.467 was found at 
DF = 220 Td and CF = 2.55 Td, and thus all static FAIMS experiments for protein 
imaging were performed at these settings. LMJ-SSP profiling experiments of rat brain 
tissue sections were performed with and without FAIMS separation in the positive ion 
mode under identical experimental conditions. A clear increase in the relative abundances 
of multiply charged protein peaks was observed in the mass spectra when FAIMS was 
applied at optimized voltages for protein transmission (Figure 3.6A, from m/z 600–1300), 
despite a 1 order magnitude drop in total ion current. In total, 84 species attributed to 
proteins and/or proteoforms were detected using LMJ-SSP-FAIMS, 66 of which were not 
detected by LMJ-SSP alone. For example, the protein isotope pattern for the 9+ ion at m/z 
821.218 was clearly resolved with a S/N of 28 using LMJ-SSP-FAIMS, while 




Figure 3.6. Static LMJ-SSP-FAIMS-MS profiling and imaging of rat brain tissue for 
protein detection.  
(A) LMJ-SSP-MS spectra of a rat brain tissue section, analyzed without FAIMS and with 
FAIMS optimized for transmission of mid-mass range proteins (4–12 kDa). Different 
colored labels represent different charge states of same proteins. (B) Isotope patterns of 
an unidentified protein (z = 9) and (C) ubiquitin (z = 10), with (red) and without (black) 
FAIMS applied, showing absolute signal intensity and S/N enhancements with the 
addition of FAIMS. Without FAIMS and with FAIMS mass spectra are averages of a line 
scan, consisting of 75 scans each. (D) LMJ-SSP-MS and LMJ-SSP-FAIMS-MS ion 
images of rat brain tissue for six representative protein species including ubiquitin, 






SSP alone, 67 proteins were detected, 49 of which were not detected by LMJ-SSP-
FAIMS. This effect is attributed to lower transmission of proteins with molecular weight 
outside of the optimized FAIMS parameters (4–12 kDa), as well as to the loss of total 
signal intensity associated with FAIMS.84 Out of the six protein species detected by both 
approaches, four were observed at a slightly higher absolute signal intensity using 
FAIMS, while enhancement of S/N was observed for all six of the proteins. For example, 
a 7-fold increase in S/N (from 23 to 180) was observed for the 10+ ion cluster at m/z 
857.468 when FAIMS was applied (Figure 3.6C). A list of the deconvoluted molecular 
weights of all protein and proteoform species detected using LMJ-SSP-FAIMS and LMJ-
SSP alone is shown in Figure B.4. 
In an effort to identify detected proteins, top-down CID tandem MS was 
performed on protein ions during rat brain tissue LMJ-SSP analysis. The 9+ charge state 
at m/z 857.370 (MW = 8559.61 Da) was identified as ubiquitin with a P-score of 8.9 × 
10–53 (32% sequence coverage, Figure B.5 and Table B.1). The 6+ ions at m/z 828.256 
(MW = 4960.48 Da) were identified as thymosin β-4 with a P-score of 2.5 × 10–11 (33% 
sequence coverage, Figure B.6 and Table B.2). Myelin basic protein (MBP) was 
tentatively attributed to the 20+ ion cluster at m/z 706.968 (MW = 14113.23 Da) with a 
P-score of 3.1 × 10–6 (21% sequence coverage). The cluster of 18+ ions at m/z 845.271 
(MW = 15187.75 Da) was identified as hemoglobin α-1/2 with a P-score of 9.5 × 10–
18 (21% sequence coverage, Figure B.7 and Table B.3). High mass accuracy 
measurements were used to confirm protein identity, yielding mass errors below 10 ppm 
for all identified protein ions 
LMJ-SSP with and without FAIMS separation was performed on serial rat brain 
tissue sections in the positive ion mode. Figure 3.6D shows 2D ion images of selected 
protein species obtained using LMJ-SSP with a spatial resolution of ∼630 μm. The 
 55 
increase in S/N achieved with LMJ-SSP-FAIMS approach allowed for clear visualization 
of the spatial distribution of the proteins within the optimized transmission range. For 
example, the spatial distribution of the 9+ charge state of an unidentified protein 
(m/z 939.848, MW = 5449.60 Da) by LMJ-SSP alone was unclear, with signal due to 
protein detection and background noise observed throughout the tissue section and the 
surrounding glass slide. However, the LMJ-SSP-FAIMS image clearly shows protein 
distribution at higher relative abundances within the white matter of the rat brain. The 
same trend was seen for the protein detected at m/z 915.151. LMJ-SSP-FAIMS-MS 
imaging also allowed visualization of the spatial distribution of the 6+ charge state of 
thymosin β-4 (m/z 828.256) within the hippocampus of the rat brain (delineated over 
optical image of H&E stained tissues), while the 10+ charge state of ubiquitin 
(m/z 857.370) was distributed homogeneously throughout the tissue section. Protein 
distributions obtained by LMJ-SSP-MS imaging were reproducible (n = 4 for each 
approach,  Figure 3.7), although small alterations in experimental parameters including 
pressure and probe distance to the sample slightly affected ion intensity, which most 
noticeably impacts ion images obtained for ions that are not localized in a specific region 
of the tissue. Similar spatial distributions for these proteins described have been recently 
reported using other ambient ionization MS imaging techniques.67,82 
Proteins with molecular weights outside the optimized FAIMS voltages are 
observed at lower absolute intensities when compared to LMJ-SSP alone. For example, 
MBP has a molecular weight of 15 kDa which is outside the 4–12 kDa range. LMJ-SSP-
FAIMS-MS imaging of its 20+ charge state at m/z 706.968 still allows for visualization 
of its spatial distribution despite a 2-fold reduction in intensity. Note that lipid ions could 
still be detected and imaged using the FAIMS conditions optimized from proteins,  
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Figure 3.7. Ion images of three representative proteins on replicates (n=3) of serial 
sections of rat brain tissue half sections to show consistency of ion 












Figure 3.8. LMJ-SSP-FAIMS-MS lipid and protein ion images obtained through selective 

















although at lower relative and absolute abundances. For example,  Figure 3.8 shows the 
ion images obtained from an unwashed rat brain tissue section for m/z 760.584, PC 
(34:1), m/z 810.597, PC (38:4), and m/z 857.370, ubiquitin, which were detected during 
the same LMJ-SSP-FAIMS-MS imaging experiment. 
3.3.5 LMJ-SSP-FAIMS-MS imaging of proteins in ovarian cancer tissue sections 
The integrated LMJ-SSP-FAIMS approach was applied to image proteins in 
human normal ovarian and high grade serous ovarian cancer tissue samples. 2D ion 
images revealed distinct spatial distribution of various protein ions within the tissue 
sections, as shown in Figure 5b for four selected protein ions: 10+ ion cluster at m/z 
857.963 (MW = 8559.54 Da), identified as ubiquitin (P-score = 1.6 × 10–20, 13% 
sequence coverage, mass error of 9.35 ppm, Figure B.8 and Table B.4); 5+ ion cluster at 
m/z 993.501 (MW = 4960.46 Da), identified as thymosin β-4 (P-score = 1.6 × 10–5, 12% 
sequence coverage, mass error of 6.15 ppm, Figure B.9 and Table B.5); 16+ ion cluster at 
m/z 946.311 (MW = 15116.76 Da), identified as hemoglobin α-subunit (P-score = 5.3 × 
10–11, 26% sequence coverage, mass error of −7.94 ppm, Figure B.10 and Table B.6) and 
the 9+ ion cluster at m/z 1122.038 (MW = 10084.27 Da), proposed as calcyclin (P-score 
= 5.4 × 10–12, 7% sequence coverage, mass error of 4.46 ppm). Histopathologic 
evaluation of H&E stained serial sections revealed the presence of necrotic tissue 
adjacent to the tumor cells in the tumor tissue, while the normal tissue was 
homogeneously composed of normal ovarian tissue. Comparison of the 2D ion images 
and the annotated optical images of the H&E stained samples revealed that ubiquitin, 
thymosin β-4, and calcyclin showed higher relative abundances within the tumor region 
of the ovarian tumor sample compared with both the necrosis region and the normal 
ovarian tissue. Hemoglobin α-subunit, however, showed higher relative abundances 
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Figure 3.9. Static LMJ-SSP-FAIMS-MS profiling and imaging of human normal and 
cancerous ovarian tissues. 
 (A) LMJ-SSP-FAIMS-MS spectra of normal ovarian, necrotic, and serous ovarian 
cancer samples in which different colored labels represent different charge states of same 
protein species. (B) LMJ-SSP-FAIMS-MS ion images of ubiquitin, thymosin β-4, 
calcyclin, and hemoglobin α-subunit for a normal ovarian tissue sample compared with 
the high grade serous ovarian tumor sample, containing both necrotic and tumor regions 
(spatial resolution is ∼630 μm). Optical images of H&E stained sections show regions of 


















        
           





















        
          
     
        
            
     
         
         
     
          
     
        
       
       
                    
              
    
   
                                  
   
 
  
   
   
   
   
    
   
   
      
    
 
  
   
   
      
   
   
               
 
  
   
   
    
               
       
    
      
        





within the necrosis region compared to the adjacent tumor region and the normal ovarian 
tissue. The mass spectra obtained showed distinct protein distribution for high grade 
serous ovarian cancer, necrotic ovarian tissue, and normal ovarian tissue under optimized 
LMJ-SSP-FAIMS conditions (Figure 3.9A). 
3.4 CONCLUSIONS 
We developed and optimized an analytical approach integrating DESI and LMJ-
SSP with a chip-based FAIMS device for imaging biological tissue samples. This method 
allowed for partial separation of analytes after desorption or extraction from biological 
samples, resulting in decreased chemical noise and increased detection of selected 
molecular species. Reducing interferences through FAIMS separation improved the S/N 
for the species of interest, aiding in spectra interpretation and improving ion image 
quality. Optimization of DF and CF values for semi-targeted transmission of different 
molecular classes can be performed through 2D-FAIMS sweeping experiments during a 
profiling or a more time-consuming imaging assay, directly from tissue samples.  
We show through several examples that this approach is particularly useful for 
semi-selective imaging of subsets of multiply charged lipids and proteins at optimized 
FAIMS conditions, with no increase in analysis time. For example, improvement in the 
S/N, ion abundances, and number of doubly charged CL and gangliosides species at 
optimized FAIMS conditions were observed in rat brain tissue sections. DESI-FAIMS-
MS imaging allowed enhanced detection and imaging of diagnostic CL in human 
oncocytic thyroid tumor with reduced interference from other GP species, enabling 
improved ion isolation and identification by tandem MS. LMJ-SSP-FAIMS-MS imaging 
was particularly powerful for imaging multiply charged protein ions from biological 
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tissue samples. Optimized FAIMS parameters for proteins in the 4−12 kDa range allowed 
increase in the S/N, number detected, and visualization of the 2D spatial distribution of 
84 protein species within rat brain, even with an overall decrease in total ion current. 
LMJ-SSP-FAIMS-MS imaging of human ovarian tissue samples enabled detection, 
identification, and correlation of spatial distribution of several proteins within the 
heterogeneous regions of the tissue samples, including regions of tumor, necrotic, and 
normal ovarian tissues. This is the first example of global protein imaging in human 
cancer tissue by ambient ionization MS imaging.  
Our results show that FAIMS can be successfully integrated with DESI and LMJ-
SSP for improved detection and imaging of subsets of molecular species in biological 
tissues. While separation using the planar FAIMS device caused a decrease in total ion 
abundance of 1 order of magnitude or more, an increase in S/N ratio due to concomitant 
reduction of noise level contributed to improved data quality for MS imaging 
experiments.84 Thus, addition of FAIMS to a DESI or LMJ-SSP MS imaging workflow at 
optimized conditions is valuable for the detection and spatial visualization of otherwise 
undetectable lipids and proteins of diagnostic importance in biological tissues. Yet, while 
FAIMS provides a separation capability to increase data quality in ambient ionization MS 
imaging, ion suppression and matrix effects during ionization are still pertinent and 
should be considered as these may hinder ionization of molecules of interest.63 
 Further optimization of the integrated system is being pursued to increase 
sensitivity and ion transmission. As with other MS imaging techniques, the extent of 
molecular information obtained is significantly less than that achieved with standard 
HPLC-MS approaches. For example, HPLC-MS proteomic assays of selected tissue 
regions obtained by laser capture microdissection can be performed at similar spatial 
resolution as LMJ-SSP, although more time-consuming and labor intensive.91 Evaluation 
 62 
of the molecular coverage achieved when compared to standard chromatographic 
separation techniques will be sought to better quantify the utility of our approach. 
However, as ambient ionization MS imaging provides molecular and spatial information 
at a fraction of the time, without extensive sample preparation, we expect the integrated 
approach described here to be valuable in biomedical applications targeted at imaging 
specific diagnostic lipids and proteins which are otherwise difficult to detect in biological 
tissues.  
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Chapter 4: Double bond characterization of free fatty acids directly 
from biological tissue samples by ultraviolet photodissociation3 
4.1 INTRODUCTION 
Free fatty acids (FA) have a variety of roles within eukaryotic cells that are vital 
to cellular structure and functions. Often termed the “building blocks” of lipids, FAs play 
a crucial role in the formation of cell membranes and often contribute to their biophysical 
properties. Acyl chain length, degree of unsaturation, and double bond position of the FA 
chains of lipids dictate membrane fluidity, which can often affect biological processes 
occurring within or near cells.92 FAs are also a significant source of energy for cells as 
they can be completely oxidized into CO2 by beta-oxidation, in turn producing energy-
rich adenosine triphosphates to power cellular processes.93 Cells can obtain FAs in two 
ways: scavenging from exogenous sources or by de novo synthesis through FA synthase. 
Typically, healthy cells rely predominantly on the former to source their required FAs. 
However, cancerous cells have shown to produce FAs endogenously in order to supply 
the molecules required for rapid cell growth.94 Increased level of FA synthase has been 
observed  in breast95,96, ovarian97, and prostate98 cancers, resulting in increased 
abundance of FAs within the tissues and blood of these patients. Additionally, FA 
synthase overexpression has been associated with more aggressive forms of cancer. 
Kuhajda et al., for example, found that  overexpression of the functional FA synthase 
OA-519 was associated with an aggressive form of breast cancer and increased de novo 
FA synthesis.99 Due to this difference between healthy and cancerous cells, there has 
been a strong interest in understanding the alterations in FA composition caused by 
 
3 Adapted with permission from “Feider, C. L.*; Macias, L.A.*; Brodbelt, J.S.; Eberlin, L. S., Double bond 
characterization of free fatty acids directly from biological tissues by ultraviolet photodissociation.” Anal. 
Chem. 2020, 92 (212), 8386-8395. C.L. Feider and L.A. Macias contributed equally to the submitted 
manuscript, but data descibed in this chapter was collected primarily by C.L. Feider.  All authors assited in 
the preparation and editing of the manuscript. All authors revised the manuscript. 
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cancer as these differences may be exploited for determination of disease biomarkers and 
possible therapeutic targets.100,101  
Mass spectrometry (MS) is a powerful tool for the investigation of these 
alterations, allowing for both qualitative and quantitative analysis of FA within biological 
samples. For example, liquid chromatography (LC) MS couples with electrospray 
ionization (ESI) of biological extracts allows for the detection of deprotonated FA anions, 
facilitating investigation of the sum composition of FA within a sample based on the 
exact mass measurements of the ions.102,103 Additionally, the structural information of 
FAs responsible for membrane properties, such as branching, degree of unsaturation, and 
double bond location, can be evaluated with the use of tandem MS (MS/MS). 
Unfortunately, the primary ion activation technique, collision induced dissociation (CID), 
does not provide this informative information. Low energy collisional activation of FA 
typically results in fragmentation of the most labile bonds proximal to the carbonyl 
group, producing neutral loss fragments of water and carbon dioxide rather than 
structural information about the acyl chain.104,105 To bypass this limitation, three main 
strategies have been developed: double bond derivatization, charge-switching, and 
implementation of alternative ion activation methods.106-111 Double bond derivatization 
techniques, such as the Paternò-Büchi reaction107,112,113 and meta-chloroperoxybenzoic-
acid (m-CPBA) epoxidation114,115 have been implemented to modify the double bonds to 
make them amenable to fragmentation by CID, resulting in informative double bond 
products upon activation. Charge-switching strategies, in contrast, involve the 
modification of the carboxyl group to promote cationization and dissociation of the acyl 
chain of FA through stabilization of the fragile bonds near the carboxylic acid. These 
methods, which include non-covalent metal adduction,116 head group derivatization,108,117 
and gas phase ion/ion reactions,109,110 yield products informative of the double bond 
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position when applied to the fragmentation of FA. The use of alternative ion activation 
methods that facilitate higher-energy fragmentation pathways, such as ultraviolet 
photodissociation (UVPD),118,119 ozone-induced dissociation (OzID),120 and electron-
induced dissociation (EID),121 are also promising techniques for the localization of 
double bonds in lipids and integration with these activation methods with charge-
switching strategies have been successful in elucidating FA structures.122-125 Ultraviolet 
photodissociation, in particular, has been shown to provide detailed structural information 
including double bond and sn-position from phospho- and sphingo- lipid isomers as well 
as isomers from cationized FAs.118,119,124,126 UVPD fragmentation of unsaturated lipids 
produces diagnostic product ions with a mass difference of 24 Da due to cleavage of the 
bonds adjacent to the double bonds, thus allowing for confident localization of the double 
bonds. 
While shotgun and chromatographic analyses of biological extracts allow 
sensitive and in-depth investigation of the metabolic alterations in biological samples, 
they do not provide insight into the distribution or spatial localization of FAs or lipids in 
tissue. Human cancer tissues, for example, often present complex histology including 
viable tumor regions within necrotic tissue, healthy stroma, calcifications, connective 
tissue, and regions of inflammation. As each of these cell populations undergoes unique 
metabolic processes, tissue homogenization precludes precise identification of the 
molecular alterations occurring within tissue regions that are enriched with a specific cell 
type. Alternatively, MS imaging techniques allow acquisition of spatially accurate 
molecular information with the spatial resolution needed to correlate molecular and 
histologic information directly from tissues sections. Desorption electrospray ionization 
(DESI) MS, for example, has been extensively used to investigate the metabolic 
alterations occurring in diseased tissues, especially lipids.127,128 For example, DESI-MS 
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imaging has been used to identify alterations in free FA in a variety of human tissues 
including cancer.128,129 To improve detection of FA directly from tissues, the inclusion of 
silver ions and dicationic compounds (DCs) in the DESI solvent system has been used to 
enable detection of negatively charged lipids in the positive ion mode.130,131  DESI and 
other MS imaging techniques have been integrated with double bond elucidation methods 
to investigate lipid isomerism within tissue sections. For example, matrix assisted laser 
desorption/ionization (MALDI) has been integrated with gas-phase OzID and Paternò–
Büchi derivatization for the imaging of double bond and sn-positional isomers of 
phosphatidylcholines (PC), glycerophospholipids (GP) and glycosphingolipids in mouse 
brain tissues.132,133 Tang et al. integrated online Paternò–Büchi derivatization with a 
liquid microjunction surface sampling probe (LMJ-SSP) to perform in situ isomeric ratio 
analysis of free FA and PC lipids in healthy and disease mouse tissue sections.134 Kuo et 
al. utilized offline m-CPBA derivatization coupled to DESI-MS imaging to resolve FA 
isomers within kidney and metastatic lung tissue sections from murine cancer models.115 
Both works by Kuo et al. and Tang et al. showed significant alterations in the double 
bond position of FA 18:1, either free or conjugated to GP, within the murine cancerous 
tissue, suggesting dysregulation of FA synthase.  
Previous work from our group shows the integration of 193 nm UVPD with DESI 
on an Orbitrap platform for MS imaging of GP isomers in biological tissue sections.135 
Using this approach, isomeric double bond distribution was observed in tissue sub-
regions of different histologic composition in human tissue samples. For example, the 
11Δ positional isomer of PC 18:1_18:1 was found at higher relative abundances in 
normal lymph node tissue when compared to the abundance within an adjacent thyroid 
metastasis, suggesting differential uptake of synthesis of FAs between these tissue types. 
In the present study, we used 193 nm UVPD coupled to reactive DESI to evaluate 
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double-bond positions in charge-inverted free FAs directly from biological tissue sections 
and uncovered differences in free FA isomer compositions between molecular subtypes 


































4.2 MATERIALS AND METHODS 
4.2.1 Chemicals 
All chemicals for the synthesis of the stable DC compounds, including 1,6-
dibromohexane, 1,8-dibromooctane, 1-methylpyrrolidine, 1-ethylpyrrolidine, ethyl 
acetate, isopropyl alcohol, and phosphorus pentoxide were purchased from Sigma 
Aldrich (Milwaukee, WI). FA standards were purchased from Sigma-Aldrich (St. Louis, 
MO) and used without further purification. High purity methanol and acetone used for 
DESI-MS imaging was purchased from Fisher Scientific (Hampton, NH). 
4.2.2 Synthesis and evaluation of dicationic compounds 
Four DCs, displayed in Table C.1, were synthesized following established 
procedures reported in the literature.136-138 All possible combinations of 1,6-
dibromohexane, 1,8-dibromooctane, 1-methylpyrrolidine, and 1-ethylpyrrolidine were 
used to produce the four compounds under the same synthetic conditions. The four 
compounds were evaluated for efficient complexation with free FAs during DESI-MS 
analysis and for reduction of interfering fragment ions produced by UVPD. Due to a 
fragment ion produced from the 1-methylpyrrolidine containing compounds interfering 
with the distal diagnostic peak from the FA 18:1 (11Z) isomer (Figure C.1), the 1-
ethylpyrrolindine compounds were selected as optimal for the present application. The 
synthetic yield of C8(epy)2-Br, termed 1,8-ethyl DC, was greatest and thus utilized for all 
experiments described in this work. 
4.2.3 Tissue samples 
Optimization of parameters was performed using mouse brain tissue samples, 
purchased from BioIVT (Westbury, NY). Frozen human tissue samples were obtained 
 70 
from the Cooperative Human Tissue Network (CHTN) and Asterand Biosciences 
(Detroit, MI) under approved IRB protocols. Samples were stored in a -80C freezer until 
sectioned. Tissue samples were sectioned at 10 µm thick using a CryoStar NX50 cryostat 
(Thermo Scientific, Waltham, MA) and thaw mounted on glass slides. After sectioning, 
the glass slides were stored at -80C. Immediately prior to MS imaging, the glass slides 
were thawed and dried for ~15 min.  
4.2.4 DESI-UVPD MS imaging 
Mass spectra were collected on a Thermo Scientific Orbitrap Fusion Lumos mass 
spectrometer (San Jose, CA) modified to perform UVPD in the dual linear ion traps with 
a 193 nm Coherent Excistar excimer laser (Santa Cruz, CA) as previously described.139 a 
2D Omni Spay DESI imaging platform (Prosolia Inc. Indianapolis, IN) was coupled to an 
Orbitrap Fusion Lumos mass spectrometer (Thermo Scientific, San Jose, CA) using an 
adaptor (Prosolia, Indianapolis, IN) and a lab-built extended capillary, as described 
previously.135 The DESI solvent system utilized was methanol:acetone 80:20 with 15 µM 
1,8-ethyl DC at a flow rate of 7 µL/min, yielding a pixel size of the MS image of 200 µm. 
The complexed FAs were isolated in the quadrupole and subjected to 193 nm UVPD in 
the high-pressure ion trap with 20 laser pulses at 4 mJ per pulse. DESI-UVPD-MS 
imaging was performed in the positive ion mode with an isolation width of 1.5 m/z 
centered at the mass of interest and a resolving power of 30,000. The maximum injection 
time was set to 1800 msec to obtain optimal signal-to-noise of fragment peaks. Imaging 
data was acquired in full profile mode. 
 71 
4.2.5 2D image processing 
Thermo RAW files were converted to mzML files using msConvert 
(ProteoWizard) using a threshold peak filter of 50 to reduce file size.140 mzML files were 
then imported into R using the mzR package from Bioconductor repository. Images were 
constructed for each m/z value using the intensity of the exact m/z value ± 0.02 Da. 
4.2.6 Data extraction and statistical analysis 
After DESI-MS imaging of breast carcinoma tissues, the same sections analyzed 
were stained with hematoxylin and eosin (H&E) and evaluated by a pathologist for 
determination of regions of pure tumor tissue. Converted mzML files were then compiled 
into an imzML data format using imzML converter141 and uploaded into MSiReader for 
extraction of the double bond diagnostic m/z peaks within areas of breast carcinoma 
tissue.142 Extracted data was then imported into R and the 9Δ /11Δ ratios for each pixel 
were calculated. Non-parametric t-tests of the data were performed by calculating the 
mean log ratio of the diagnostic ions was calculated for each sample, followed by 
calculation of the mean for the tissue subsets to be analyzed (metastatic vs. non-
metastatic, estrogen receptor (ER) positive vs. ER negative, and progesterone (PR) 
positive vs. PR negative). We then permuted the sample log means between the two 
groups and calculated the hypothetical distribution of the permutated sample sets 
(repetitions = 5000). The p-values were calculated by dividing the number of times the 
absolute mean difference of the observed value was smaller than the absolute value of the 
permuted mean by the number of repetitions. As three hypotheses were tested using the 
same data, a Bonferroni correction was applied resulting in a new significance cutoff 
value of α = 0.0167.  
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4.2.6 Nomenclature 
Lipid shorthand, as described by Liebsich et al., was adopted.143 FA structures are 
described by the number of carbon atoms, followed by a colon and the number of double 
bonds. Carbon positions are described relative to the carboxyl carbon (C1). If the position 
of the double bonds is known, it is indicated in parentheses following the number of 
double bonds. The double bond geometry is indicated by Z (for cis), E (for trans), or ∆ 
(for unknown) following the double bond position. For ease of discussion, fragment ions 
arising from cleavage of C-C bonds adjacent to C=C double bonds are referred to as 
proximal (e.g. ∆p) and distal (e.g. ∆d) in reference to the C-C bond on the carboxyl- and 
methyl-end, respectively. 
4.3 RESULTS AND DISCUSSION 
4.3.1 Double bond localization within fatty acids by dication complexation and 
UVPD  
Our collaborators, Prof. Jennifer Brodbelt and Luis Macias, first explored the 
utility of 193 nm UVPD in cleaving and characterizing double bonds within deprotonated 
FAs in the negative ion mode. Application of this activation method to free FAs was 
explored and shown to result in low abundance fragment ions that paralleled the 
dissociation pathways of phospo- and sphingolipids. However, the intensity of these 
diagnostic fragments was extremely low, about 0.030% of the total ion current in the 
spectra, which precludes integration with a lower sensitivity ionization technique such as 
DESI-MS. Additionally, 193nm UVPD of polyunsaturated FAs yielded uninformative 
neutral losses and dissociation of C-C bonds, precluding the ability to assign double bond 
positions. As charge-switching strategies have shown ability to increase the efficiency of 
fragmentation for double bond elucidation, similar methods were explored for integration 
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into a DESI-UVPD imaging workflow. Specially designed dications (DCs), for example, 
have been shown to readily adduct and charge-invert free FAs from negative to positive 
ion mode without compromising sensitivity when implemented in a DESI 
workflow.131,137 In this approach, the anionic carboxylate group present on the FA 
structure binds electrostatically with the DC possessing a fixed 2+ charge, generating a 
DC-FA complex with a net +1 charge. Although collisional activation of non-covalent 
DC●lipid complexes is dominated by neutral losses from the dication group,131 193 nm 
UVPD has been shown to yield product ions that retain non-covalent interactions. 
Additionally, reactive DESI-MS of mouse brain tissue sections with DC molecules doped 
into the spray solvent, as outlined in Lostun et al., enables formation of the DC●FA 
complexes  with high efficiency.131 We thus explored reactive DESI-MS imaging of a 
tissue section in tandem with UVPD of the DC●FA complexes to acquire spatially 
correlated information regarding the distribution of FA isomers within heterogenous 
biological tissues.  
4.3.2 DESI-UVPD MS imaging of isomers in monounsaturated fatty acids  
DESI-MS was coupled to an Orbitrap Fusion Lumos mass spectrometer equipped 
with a 193 nm excimer laser to perform UVPD-MS imaging of a human ovarian tumor 
tissue sample containing a region of high grade serous ovarian carcinoma adjacent to a 
region of normal ovarian tissue. The molecular profile of the ovarian tissue acquired in 
the full m/z 500-1000 range showed high abundance of FA species complexed with DC 
(Figure 4.1, Table 4.1), including various saturated, mono- and polyunsaturated FA 
species normally detected from biological tissues using DESI-MS imaging in the 
negative ion mode of biological tissues. DC complexed to other GP species, primarily 




Figure 4.1. Full MS profile of ovarian tumor tissue analyzed by DESI-MS in the positive 


































Figure 4.2. DESI-UVPD MS imaging of the distribution of the FA 18:1 double bond 
isomers within an ovarian tumor tissue.  
(A) The DESI-UVPD spectrum shows two pairs of diagnostic ions resulting from the 
fragmentation of the 9Δ and 11Δ positional isomers. (B) The ion images from the 
precursor ion (m/z 591.58), the proximal fragment peaks for each isomer (9Δp at m/z 
453.44 and 11Δp at m/z 481.47), and the 9Δp:11Δp ratio, illustrating that there is no 
observable difference in the isomer distribution when comparing the tumor and normal 










these species were not explored in this study. The most abundant complex of m/z 591.581 
identified as DC●FA 18:1 was targeted for UVPD. Figure 4.2A shows an average UVPD 
mass spectrum of the m/z 591.581 complex acquired during DESI-MS imaging across the 
tissue section, resulting in two pairs of diagnostic products characteristic of a mixture of 
9Δ and 11Δ FA 18:1 isomers. The relative abundance of the 9Δ ions of m/z 453.44 and 
m/z 477.44 was approximately one order of magnitude higher than those from the 11Δ 
ions of m/z 481.47 and m/z 505.47 across the tissue section. To investigate the spatial 
distribution of the isomers more closely, ion images of the precursor ion, the proximal 
isomeric fragments (9Δp and 11Δp), and the 9Δp:11Δp ratio were generated (Figure 4.2B). 
All images showed consistent signal intensity across the tissue section, including the 
normal and tumor ovarian tissue regions, with the normal region having a log mean ratio 
of 0.779 ± 0.123 and the cancer region having a log mean ratio of 0.832 ± 0.164. This 
suggests that any alterations in the isomeric distribution of FA 18:1 between tumor and 
normal ovarian tissues from this patient are minimal and, if present, are less prominent 
than the random fluctuations in signal intensity associated with DESI-UVPD MS analysis 
(17.8% RSD for precursor ion signal and an average 27.9% RSD for Δ9 and Δ11 
fragment ions). 
4.3.3 DESI-UVPD-MS imaging of polyunsaturated fatty acid isomers  
Although UVPD of polyunsaturated FA anions was ineffective, charge inversion 
via DC complexation promoted rich UVPD mass spectra suited for double bond 
localization. UVPD fragmentation of a DC●FA 18:2 (9Z,12Z) ion by ESI yielded 
diagnostic product ion pairs at m/z 453.44/477.44 and m/z 493.47/517.47 for the 9Z and 
12Z double bonds, respectively. Similarly, 193 nm UVPD of the DC●arachidonic acid 
(FA 20:4(5Z,8Z,11Z,14Z)) complex produced four pairs of diagnostic fragments with a 
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mass difference of 24 Da (m/z 397.38/421.38 for 5Z; m/z 437.41/461.41 for 8Z; m/z 
477.44/501.44 for 11Z; m/z 517.47/541.47 for 14Z), in addition to produces resulting 
from cleavage of all C-C bonds in the acyl chain. Spectra resulting from polyunsaturated 
FA were much more complex due to photoinduced excitation and production of radicals, 
presenting challenges for application in imaging a complex sample.126 However, as 
UVPD produces ion pairs, the risk of misidentification of a double bond is reduced as 
both diagnostic products from the fragmentation on either side of the double bond would 
need to be present to suggest confident identification of the double pond positional 
isomer. Considering this limitation, DESI-UVPD MS was utilized to image 
polyunsaturated FA isomers within biological tissue sections. 
Applying DESI-UVPD MS imaging to analyze DC●FA 18:2 (m/z 589.56) 
directly from ovarian tissue confirmed that polyunsaturated FAs can also be characterized 
from biological samples. While polyunsaturated FAs within mammalian tissues have less 
varied isomeric double bond positions than monounsaturated FAs, there is diversity in the 
abundance of ω-9, ω-6, and ω-3 FAs in the human diet that may be detected in tissue 
samples. DESI-UVPD-MS imaging of DC●FA 18:2 consistently displayed the pair of 
double bond diagnostic products that would arise for FA 18:2 (9Δ,12Δ), suggesting a 
homogeneous presence of this FA within the sample (Figure 4.3). Only one fragment ion, 
at most, was observed per double bond that would correspond to the hypothetical 
diagnostic products for FA 18:2 (12Δ,15Δ) and FA 18:2 (6Δ,9Δ), as shown in Table 4.2, 
thus providing no positive confirmatory evidence for these isomers in the samples. 
DESI-UVPD-MS imaging of DC●FA 20:4 from ovarian tissue also yielded a 
complex mass spectrum, yet, all double bond diagnostic pairs of fragments for FA 
20:4(5Δ,8Δ,11Δ,14Δ), the most prominent isomer of 20:4 in nature, were observed in the 




Figure 4.3. DESI-UVPD-MS imaging of FA 18:2 from an ovarian tissue section  
(A) DESI-UVPD mass spectrum from the fragmentation of FA18:2 precursor ion of m/z 
589.56 (B) Ion images of the precursor and double bond diagnostic peaks, showing the 



















Figure 4.4. DESI-UVPD-MS imaging of FA 20:4 from an ovarian tumor tissue section  
(A) DESI-UVPD mass spectrum from the fragmentation of FA 20:4 precursor at m/z 
613.56 (B) Ion images of the precursor and select double bond diagnostic peaks, showing 




























FA 18:2, possible diagnostic fragment ions for the ω-3 FA 20:4 isomer were detected 
within the mass spectra (Table 4.3) but only one diagnostic ion corresponding to the 
cleavage of each double bond position was detected, therefore preventing confident 
identification of the presence of this isomer. 
Fragmentation of polyunsaturated FA differed from monounsaturated FA in the 
relative abundance of proximal and distal peaks. Both diagnostic fragments from 
monounsaturated lipids and FAs have typically exhibited similar ion abundances within 
each pair, but both ESI and DESI-MS results from the fragmentation of polyunsaturated 
FA show unequal relative abundances of the proximal and distal fragment ions.144 For 
example, the 9Δp fragment of m/z 453.44 is consistently more abundant than the 9Δd 
fragment of m/z 477.44.  As the ovarian tissue section is more molecularly complex than 
FA standards used in optimization experiments, there is a higher chance that interfering 
fragment ions from co-isolated species overlap with the diagnostic fragment ions and 
alter their observed abundance. To evaluate if these differences in the relative abundances 
are due to interfering ions, the ratio of the proximal and distal fragment ions was 
calculated for both ESI-MS and DESI-MS modes for both FA 18:2 and FA 20:4 (Figure 
4.5). The proximal:distal ratio for every double bond pair produced upon UVPD was 
consistent between ESI and DESI analysis, suggesting these altered ratios do not 
originate from interfering isobars but rather represent preferential cleavages across the 
FA chain or overlapping fragmentation pathways of the DC●FA complexes. 
4.3.4 Relative quantitation of double bond isomers with DESI-MS imaging 
 Previous UVPD analyses of unsaturated FAs within GPs demonstrated a linear 
relationship between the abundances of the diagnostic ions and the relative concentration 
of double bond isomers.118,145 To evaluate if DESI-MS also allowed relative quantitation  
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Figure 4.5. Comparison of distal:proximal fragment ion abundance ratios for each double 
bond for DC complex 
 (A) FA 18:2(9Z,12Z) and (B) FA 20:4(5Z,8Z,11Z,14Z) analyzed using FA standards in 










of the FA isomers, mixtures containing various molar ratios of monounsaturated FA 18:1 
(9Z) and FA 18:1 (11Z) were spotted on a PTFE surfaced and imaging of the surface was 
performed in tandem with UVPD of the FA 18:1 precursor ion (Figure 4.6). Ion images 
from the precursor ion show a consistent intensity across all sample spots at a similar 
absolute intensity value (NL≈1E5 during UVPD)  to what was detected from the ovarian 
tissue sections (NL≈8E4 – 2E5 during UVPD), allowing extrapolation of calibration 
results to biological tissue sections. In previous studies, the abundances of diagnostic ions 
corresponding to each isomer were summed together in order to increase sensitivity. 
However, UVPD of DC-FA 18:1 (9Z) resulted in an ion of m/z 505.47 that is isomeric 
with the distal fragment of FA 18:1 (11Z) (Figure 4.7A,B). The added abundance from 
the confounding product disrupts the linear relationship between the concentration ratio 
of the isomers and signal abundance of the diagnostic ions (Figure 4.7C). To circumvent 
this challenge, a calibration curve was built excluding the distal fragments from both 
isomers. Plotting ion intensities for the 9Z and 11Z proximal diagnostic ions (m/z 453.44 
and m/z 481.47, respectively) showed a clear gradient of intensities associated with 
altered concentration ratios. Plotting absolute concentration of the isomers against the 
average ion signal intensity of the respective proximal diagnostic peak for all spots 
(Figure 4.8) illustrated a linear relationship for both isomers (9Zp R2=0.9953, 11Zp 
R2=0.9965). The calculated limits of detection for the isomers were 0.568 μM and 0.492 
μM for the 9Z and 11Z diagnostic fragments, respectively, indicating that spots featuring 
the lowest concentrations of the isomers (0.5 μM) were not reliable. A DESI-MS imaging 
calibration curve was then constructed based on the ratio of isomer concentrations within 
the spots and the ratio of their resulting diagnostic fragment peak intensities for every 





Figure 4.6. Relative quantification of DESI-UVPD-MS imaging of monounsaturated 
FA●DC complexes 
(A) DESI-UVPD MS ion images of DC●FA 18:1 varying FA 18:1(9Z)/FA 18:1(11Z) 
rations. (B) Plot of the concentration ratio of FA 18:1(9Z):FA 18:1(11Z) versus the ratio 




Figure 4.7. Evaluation of interfering fragments during UVPD of FA 18:1  
(A) Illustration of isomeric fragment ion structures that preclude the use of m/z 505 as a 
diagnostic product for quantitative analyses of double bond location in DC - FA 18:1 
complex. (B) Representative UVPD mass spectrum for DC●FA 18:1 complex arising 
from a mixture of FA 18:1(9Z) and FA 18:1(11Z) standards, highlighting the m/z 505 
product composed of interfering signals from the two isomers. (C) Calibration curve built 
from the ratio of the sum diagnostic ion intensities (I(m/z 453+ m/z 471)/I(m/z 481 + m/z 505)) versus 




Figure 4.8. Calibration curves for the 9Z and 11Z proximal ions to determine limits of 














an increasing linear response with increasing concentration of the 9Z isomer in the 
mixture, as would be expected if the fragmentation efficiency of the two isomers is equal. 
Deviations from linearity can be primarily attributed to lower overall signal intensity of 
diagnostic peaks within the DESI-MS data, which is ~5% of the signal intensity achieved 
by ESI. Additionally, as no averaging was used in order to more closely resemble DESI-
MS imaging data where each pixel represents one mass spectrum, the standard deviation 
of the 9Z:11Z ratio within each spot is higher than what was obtained by direct infusion. 
Nevertheless, the linearity of the ratio concentration suggests DESI-UVPD of FA●DC 
complexes can be used for relative quantification of double bond isomers, as 
demonstrated in the next section. 
4.3.5 Investigation of double bond localization in human breast cancer subtypes 
Dysregulation of FA synthase resulting in overexpression of free FA has been 
associated with a variety of cancers, including breast carcinomas.94,146 A few MS studies 
on mouse and human breast tissues have investigated the altered FA 18:1 isomer 
distribution within normal and cancerous breast tissue. For example, Xia and coworkers 
found significant differences in the 9Δ:11Δ ratio in FA 18:1 containing 
glycerophospholipids between normal and cancerous human breast tissues as well as 
alterations in the free FA 18:1 9Δ:11Δ ratio from mouse breast tissue.106,134 However, 
further evidence has suggested that FA metabolism is altered with respect to other factors 
within breast cancer, including subtype, receptor status, and lymphatic system 
invasion.95,147 Therefore, we aimed to use DESI-UVPD-MS to evaluate the FA 18:1 
isomer distribution within breast carcinoma tissues related to various molecular and 
clinical features, including ER status, PR status, and metastatic status (invasion seen in 
sentinel lymph nodes). 
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A sample set of 18 breast tumors with detailed diagnosis and molecular subtyping 
information was used to classify samples into groups (Table C.2). Note that ER and PR 
status were not available for two samples, yielding a smaller sample set for those 
analyses. DESI-UVPD-MS imaging was performed while targeting the DC●FA 18:1 
complex. Samples were subsequently H&E stained and evaluated by a pathologist to 
determine areas of breast tumor. Breast tissue is notoriously heterogeneous, displaying 
normal, cancerous, necrotic, and fat tissue within each section, but the use of DESI-MS 
imaging allows extraction of mass spectra from tissue regions with predominant tumor 
content to ensure unambiguous correlation between molecular information and histologic 
diagnosis. The log 9Δ:11Δ ratio was calculated for each pixel and separated by three 
distinguishing features of the sample: metastatic vs. non-metastatic to sentinel lymph 
nodes, ER+ vs. ER-, and PR+ vs. PR-. Per-pixel density plots for each of these 
evaluations are shown in Figure 4.9A, B, and C. The means for each sample distribution 
and the mean difference for each evaluated parameter were calculated. All three sample 
sets showed separation in mean difference between the two groups (-0.018 for metastatic 
vs. non-metastatic, 0.109 for ER+ vs ER-, and 0.211 for PR+ vs PR-), but both the 
metastatic and ER status density plots contained shoulders that suggested incomplete 
separation of the groups. Non-parametric permutations of the samples were performed for 
each parameter to generate a random sampling of the possible mean difference values for 
these sample sets and determine the significance of the observed mean differences. 
Histograms of the randomly generated mean differences with the observed difference 
value shown as a red dotted line for each sample set are provided in Figure 4.9D, E, and 
F. Interestingly, PR status was the only mean difference that was statistically significant 
(α = 0.0187) from the generated distribution with a p value of 0.003, showing an 
increased relative abundance of the Δ11 isomer within PR+ samples compared to PR-  
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Figure 4.9. DESI-UVPD-MS imaging of FA 18:1 isomers in breast cancer tissue subtypes  
Density plots of the log of the 9Δp:11Δp diagnostic peak intensities for (A) metastatic (B) 
ER and (C) PR statuses. Histograms from the non-parametric permutation of the mean 
difference of the 9Δp:11Δp diagnostic ion abundances and the observed mean difference 
(red line) for the (D) metastatic, (E) ER, and (F) PR groupings. (G) DESI-UVPD MS 
9Δp:11Δp ratio ion images of three PR- and three PR+ breast cancer samples, showing an 
increased ratio for the PR- samples. 
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samples. The ion images of the 9Δp:11Δp ratio from 6 representative samples, 3 PR+ and 
3 PR-, allows for visual confirmation of this difference (Figure 4.9G), with PR+ samples 
exhibiting a decreased 9Δp:11Δp ratio and thus an increased relative abundance of the 
11Δ isomer. For example, the two images within the center for Figure 4.9G have 
drastically different 9Δp:11Δp ratios, with the PR- sample having an average ratio of 7.3 
while the PR+ sample had an average ratio of 2.2. This increase in the relative abundance 
of the 11Δ isomer in PR+ samples is consistent with previous studies correlating positive 
PR status with FA synthase overexpression.96 These results suggest that FA isomer 
distribution is not only related to molecular alterations between normal and cancerous 
breast tissues as suggested in studies performed with other MS methods, but may also 
correlate with aberrations in molecular processes that occur in breast cancer subtypes as 
determined by receptor status. Further studies are being performed to validate these 
trends and expand our sample set to include a larger sample cohort to adjust for patient-
to-patient variability and diverse sample populations. 
4.4 CONCLUSIONS 
Mounting evidence correlating subtle structural variations in lipids with disease 
state demands development of methods capable of both distinguishing isomeric 
biomolecules and identifying the biosynthetic dysregulation of the molecules in question. 
To this end, UVPD was coupled with reactive DESI to enhance structural lipidomics in 
an imaging workflow. Synergistic charge inversion via reactive DESI augmented the 
capabilities of UVPD for FA isomer distinction, while permitting the distribution of 
structural isomers to be spatially resolved without time-consuming off-line chemical 
derivatization. When applied to unravel FA composition of diseased tissues, this 
technique revealed molecular trends that are directly tied with molecular properties of the 
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sample. Using this method for the analysis of human breast tumor tissues suggested that 
alterations in the FA isomer abundance may be correlated to other clinically relevant 
factors in breast cancer such as PR receptor status, an outcome that merits further 
investigation. Further exploration of the relationship between FA synthase, FA isomer 
abundance ratios, and the importance of these factors within breast cancer and breast 
cancer subtypes is necessary to further understand the role FAs play in disease 
progression and patient outcome. A drawback of the current implementation of this 
methodology is the limited sensitivity when compared to that achieved through ESI 
infusion-based workflows. Alternate strategies to maintain the sensitivity of ESI without 
compromising the histological certainty that MS imaging allows such as a laser capture 
microdissection-LCMS workflow, however, could be implemented to further explore the 
tissue dependent isomer abundances detected in this study. Nevertheless, DESI-UVPD-
MS allows for spatially resolved FA isomer information without significant deviations 
from a traditional DESI-MS workflow, presenting a useful tool for the exploration of 
isomeric alterations within tissue samples.  
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Chapter 5: Molecular Imaging of Endometriosis Tissues using 
Desorption Electrospray Ionization Mass Spectrometry4 
5.1 INTRODUCTION 
Endometriosis is a debilitating disorder affecting approximately 10% of women 
within their reproductive years.148,149 The disease is characterized by the uncontrolled 
growth of endometrial tissue that lines the uterine walls into other areas of the body, 
typically within the abdominal cavity.150 Endometriosis often causes severe and chronic 
abdominal pain and subfertility, resulting in decreased quality of life for the patient and 
increased healthcare costs.151 Despite its prevalence and the detrimental effects this 
disease has on patients and the healthcare system, endometriosis remains an extremely 
perplexing disease.152 Compelling theories on the cause of endometriosis have been 
proposed, although the biological mechanisms driving endometriosis development are not 
entirely known, making disease diagnosis and management challenging.153,154 Further, as 
diagnostic biomarkers have not been identified and validated, patients are typically 
diagnosed at the time of laparoscopic surgery, which is the main treatment option for 
endometriosis patients.155,156 Endometriosis diagnosis is confirmed by post-operative 
pathologic evaluation of excised tissue upon visualization of two of the three 
characteristic histological features: endometrial glands, endometrial stroma, and 
hemosiderin. Endometrial glands and stroma found in lesions are direct evidence of 
endometrial tissue outside the uterine cavity and are histologically indistinguishable from 
the glands and stroma found within healthy uterine endometrium.157 Conversely, 
 
4 Adapted with permission from “Feider, C. L.; Woody, S.; Ledet, S.; Zhang, J.; Sebastian, K.; Breen, M. 
T.; Eberlin, L. S., Molecular Imaging of Endometriosis Tissues using Desorption Electrospray Ionization 
Mass Spectrometry. Scientific Reports 2019, 9 (1), 15690.Copyright 2019 Springer. C.L. Feider performed 
data collection and analysis and prepared the manuscript. S. Woody performed statistical analysis of the 
data. S. Ledet performed pathological evalutation of samples. J. Zhang assited with data collection. K 
Sebastian and M.T. Breen performed sample collection. L.S. Eberlin assisted with editing and preparation 
of the manuscript. All authors revised the manuscript. 
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hemosiderin is an iron-storage complex typically observed in tissue following 
hemorrhage and is associated with various diseases. Thus, hemosiderin is typically 
considered as a supporting but not a confirmatory histologic feature of endometriosis.158 
Several studies have suggested that dysregulation of biochemical pathways is a 
significant factor in endometriosis.159-161 Chan and coworkers, for example, reported 
upregulation of sphingolipid metabolism in endometriosis, leading to an accumulation of 
glucosylceramides and ceramides within the serum and peritoneal fluid of endometriosis 
patients.160 Further investigation of molecular alterations of endometriosis tissues could 
yield new insights into the pathophysiology of the disease while identifying potential 
biomarkers for preoperative diagnosis and therapy. To this end, mass spectrometry (MS) 
provides a powerful platform to investigate the molecular composition of biological 
samples and alterations occurring in a variety of diseases.162-164 In particular, MS has 
been used to determine alterations in metabolites, lipids, and proteins in serum, plasma, 
follicular fluid, urine, peritoneal fluid, and tissue biopsies obtained from endometriosis 
patients.165-171 For example, Cordeiro et al. recently used electrospray ionization to 
analyze lipids extracted from follicular fluid of ten endometriosis patients as well as ten 
healthy controls and determined significant alterations between the lipid profiles of the 
two groups.165 Similarly, Li et al. applied liquid chromatography (LC) coupled to MS to 
analyze lipid extracts of eutopic endometrial biopsies from 21 patients with 
endometriosis and 20 patients with unrelated infertility, and identified 5 potential lipid 
biomarkers that were capable of identifying endometriosis with 90.5% sensitivity and 
75.0% specificity.171 Nevertheless, the intricacies of endometriosis often complicate 
identification of biomarkers causally related to the disease. Endometriosis patients often 
suffer from other diseases such as autoimmune and endocrine disorders, and present 
increased risk of gynecological cancers172-174 This comorbidity typically results in poor 
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sensitivity and specificity of endometriosis biomarkers, making biomarker discovery 
difficult.175 Additionally, the heterogeneous histologic nature of endometriosis lesions 
presents a challenge for traditional MS analysis, as homogenization of tissue specimens 
prior to MS analysis leads to mixing of lesions with surrounding tissues, potentially 
affecting the assay specificity for biomarker identification. 
MS imaging presents an intriguing approach to study endometriosis tissues. MS 
imaging enables two dimensional analysis of biological samples, yielding spatially 
resolved molecular information that can be unambiguously correlated to histologic 
features.176 In particular, MS imaging is powerful for the analysis of heterogeneous 
tissues, as pixel-by-pixel analysis allows segregation of tissue regions, thereby increasing 
statistical power to investigate discerning molecular features within regions of interest.177 
The most widely used MS imaging technique, matrix assisted laser desorption/ionization 
(MALDI),178 has been successfully implemented towards the analysis of biological 
tissues and the detection of various diseases. Alternatively, desorption electrospray 
ionization (DESI) is an ambient ionization MS imaging method in which a spray of 
charged solvent droplets is directed towards a sample surface to desorb, ionize, and 
transport molecules to the mass spectrometer for analysis.179 DESI requires minimal to no 
sample pretreatment and as a soft ionization technique enables ionization and detection of 
intact molecular ions.18 Further, histologically compatible DESI solvent systems allow 
direct comparison of molecular ion images with histological tissue features on the same 
tissue section for improved data correlation.21 Here, we describe a MS imaging study 
utilizing DESI-MS to spatially and chemically characterize ectopic endometrium from 
endometriosis lesions and eutopic endometrium prospectively collected from 
endometriosis patients with the aim of investigating the metabolic differences between 
eutopic and ectopic endometrial tissues. 
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5.2 MATERIALS AND METHODS 
5.2.1 Tissue sample collection 
Human endometriosis lesions (n = 234) and eutopic endometrial tissue (n = 35) 
were prospectively collected from 89 patients undergoing both conservative and radical 
endometriosis surgeries by Dr. Michael T. Breen at Dell Medical School. Tissues were 
collected under approved IRB protocols from both the University of Texas IRB and the 
Seton Family of Hospitals IRB. Informed consent was obtained from all patients 
participating in this study. All endometriosis lesions samples were excised using unipolar 
electrical scissors during a laparoscopic procedure, while eutopic endometrium samples 
were collected only from patients undergoing full hysterectomy using a standard scalpel 
after the completion of the procedure. Samples were stored at 4 °C in airtight containers 
atop moist gauze until they could be flash frozen in liquid nitrogen, typically within 6 
hours of excision. Samples were then stored in a freezer until sectioned. Tissue samples 
were sectioned at 16 µm thick sections using a CryoStar NX50 cryostat (Thermo 
Scientific, Waltham, MA) and thaw mounted onto glass microscope slides. After 
sectioning, the glass slides were stored in a −80 °C freezer. Prior to MS imaging, the 
glass slides were dried in a desiccator for ~15 min. 
5.2.2 Chemicals 
The acetonitrile and dimethylformamide used for the DESI-MS spray solvent 
were purchased from Fisher Scientific (Waltham, MA) and Sigma Aldrich (St. Louis, 
MO), respectively. All solvents used for histological staining, including methanol, 
hematoxylin, bluing reagent, eosin y, ethanol, and xylenes were purchased from Fisher 
Scientific (Waltham, MA). 
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5.2.3 DESI-MS imaging parameters 
All experiments performed were carried out in accordance with the approved IRB 
protocol. A DESI 2D system (Prosolia Inc., Indianapolis, IN) was used for tissue imaging 
at a pixel size of 100 µm. DESI-MS imaging was performed in the negative ion mode 
from m/z 100–1500, using a hybrid LTQ-Orbitrap Elite mass spectrometer (Thermo 
Scientific, San Jose, CA) at 60,000 resolving power (at m/z 200) using 
dimethylformamide:acetonitrile 1:3 (v/v) at a flow rate of 1.4 µL/min unless otherwise 
stated. The approximate time-per-scan was 1.24 seconds with a stage speed of 94.3 μm/s. 
The mass accuracy obtained was <10 ppm. All DESI-MS spectra shown throughout the 
manuscript are an average of approximately 5 scans. Ion images were assembled using 
Biomap (Novartis) software. The ion images were made using the absolute ion intensity 
counts from the spectra, with 6000 counts corresponding to 100% relative abundance. 
The ion images were smoothed using the interpolate function within BioMap. All DESI-
MS imaging data is available on METASPACE.180 
5.2.4 Histopathology and light microscopy 
The same tissue sections analyzed by DESI-MS imaging were stained using 
standard hemotoxilyn and eosin (H&E) staining protocol. Pathologic evaluation was 
performed by Dr. Suzanne Ledet. Regions of definite and probable endometrial stroma, 
endometrial glands, and hemosiderin were located within the endometriosis lesions. 
Eutopic endometrial tissue was confirmed by pathology and regions containing pure 
endometrial tissue were noted. Light microscopy images of the H&E stained slides were 
taken using the EVOS FL Auto Cell Imaging System (Invitrogen, Thermo Fisher 
Scientific, Waltham, Massachusetts, USA). 
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5.2.5 Identification of molecular ions 
Metabolite and lipid species were identified using high mass accuracy 
measurements and collision induced dissociation (CID) and high-energy collision 
induced dissociation (HCD) tandem MS analyses, performed using the Orbitrap as the 
mass analyzer of the LTQ-Orbitrap Elite mass spectrometer. Fragmentation was 
performed by rastering the DESI source over serial tissue sections at an increased flow 
rate (3 μl/min). The isolation window used was 1 m/z with an energy ranging from 10–30 
normalized collision energy for CID and 40–90 for HCD. Fragmentation patterns were 
compared to literature reports and compared to data from Lipidmaps 
(www.lipidmaps.org) and Human Metabolome Databases (www.hmbd.ca). Lipids were 
characterized by fatty acid composition, but the stereochemistry of the chains and double 
bond position is unknown. 
5.2.6 Statistical analysis 
A total of 22 of the 35 eutopic endometrial tissue sections analyzed and 76 of the 
196 ectopic endometriosis tissue sections analyzed from a total of 51 patients (Table D.1) 
contained endometrial stroma and thus could be used for statistical analysis. Lasso 
statistical analysis of the DESI-MS imaging data was performed to build a classification 
method capable of distinguishing between eutopic and ectopic endometrial tissue, 
identify biological features of greatest importance within this classification model, and 
evaluate if the molecular alterations of endometriosis are independent of lesion location. 
MS imaging data was converted to an mzML format using MS Convert (version 
3.9.11748) and imzML format using imzMLConverter (version 1.3) opensource software 
programs without the addition of any data filters.181,182 DESI-MS imaging data from pure 
histological regions of endometrial glands and stroma from endometriosis lesions and 
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endometrial tissue were extracted using MSiReader software.183 The m/z range was 
discretized by performing hierarchical clustering and cutting the resulting dendrogram at 
distance 0.05. Peaks appearing in more than 10% of the pixels were retained for analysis, 
and intensities for each spectrum were normalized by their median non-zero intensity. 
The samples were randomly divided into training, validation, and test sets of samples. A 
logistic regression model was constructed using lasso regularization36 with the glmnet 
package in the R programming language,184 and the lasso complexity penalty was 
selected using five-fold CV. The first penalization parameter selected yielded a model 
containing 6 background ions, potentially due to batch effects incurred during the 
analysis. To alleviate this, we considered models using a larger complexity penalization 
parameter resulting in fewer selected features, even if their performance in CV was lower 
than the original selected model. The final model was selected to optimize the overall 
PPA, NPA, and accuracy of the training and validation sets, while minimizing the ratio of 
background ion to tissue-specific features. To evaluate the performance of the final 
selected model, PPA, NPA, and overall agreement of the test set is reported. In our study, 
PPA describes the true positive rate for the identification of ectopic endometrial tissue 
while NPA describes the true negative rate. 
The same preprocessing methods used for the lasso statistical analysis were also 
used for the bootstrap empirical Bayes analysis, including hierarchical clustering, peak 
filtering, and normalization. After preprocessing, we calculated the log-ratio of mean 
intensities between the two groups. Then, we used the bootstrap method to estimate 
standard errors for these log-ratios. Specifically, for one bootstrap sample of the log-ratio 
of mean intensities for one feature, we resampled with replacement the intensities for that 
feature from all pixels, retaining the group label. The z-values were calculated as the 
observed log-ratio of mean intensities, divided by their standard error. The observed test 
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statistics and their standard errors are shown in Figure D.1, and it is clear that the vast 
majority of features are statistically significantly different from zero, when considering 
the traditional sharp null hypothesis of no difference in mean intensity between the two 
groups of pixels. Therefore, we then carried out an empirical Bayes analysis to detect 
“interesting” features.185 Briefly, this approach assumes a two-groups model for observed 
test statistics, that features are either “interesting” or “uninteresting,” and that both groups 
of features have a corresponding distribution, called the alternative and null distributions, 
respectively. This deviates from the usual approach of sharp hypothesis tests of no 
difference in expression level. We estimate the null distribution empirically, assuming it 
is normally distributed, and we use moment matching from the middle two quartiles of 
test statistics to estimate the mean and variance of this normal distribution. The full 
mixture density is estimated using a spline interpolation of a histogram of all the test 
statistics (Figure D.2). The prior probability of features being “uninteresting” is estimated 
using these two estimated densities. From these components we calculate the local FDR, 
or posterior probability of being “uninteresting,” for each feature, and report features for 
which the local FDR is less than 20%. 
Principal component analysis (PCA) was used to evaluate quantitative differences 
in the data owing to subtype. Intensities for each mass spectra were normalized by the 
median-log non-zero intensity to account for higher intensity peaks showing higher 
variance, and thus poorly representing the overall variance in the spectra.186 
5.3 RESULTS AND DISCUSSION 
5.3.1 Molecular imaging of endometriosis lesions and eutopic endometrium 
A total of 269 samples from 89 patients undergoing endometriosis resection 
laparoscopies were collected for our study: 234 endometriosis lesions excised from a 
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variety of locations within the abdominal cavity including the peritoneum, serosal regions 
of organs such as the rectum, ligaments, ovaries, and fallopian tubes as well as 35 eutopic 
endometrial tissues collected from a subset of patients undergoing full hysterectomies. 
The tissues were obtained from patients ranging in ages from 19 to 54 years old. 
Summaries of the patient demographics are provided in Tables D.2 and D.3. No patient 
exclusions criteria were applied, therefore samples from patients taking hormonal 
contraceptives to alleviate endometriosis symptoms were included, as well as patients at 
different time within their menstrual cycles. Of the 234 endometriosis samples, 38 were 
not analyzed with DESI-MS due to quality control issues such as small sample size (<50 
mg) or incorrect gross anatomy tissue diagnosis during surgery. 
Figure 5.1A shows selected DESI mass spectra of endometrial stroma from an 
ectopic endometriosis tissue collected from rectum and eutopic endometrial stroma 
obtained from two different patients. DESI-MS imaging of the tissue sections allowed 
detection and subsequent identification of a variety of small metabolites and lipids 
including free fatty acids (FA), sphingolipids such as ceramides (Cer), and 
glycerophospholipids, such as glycerophophatidic acid (PA), 
glycerophosphoethanolamine (PE), glycerophosphoglycerol (PG), glycerophosphoinisitol 
(PI), glycerophosphoserine (PS), and cardiolipin (CL). Note that lipids species are 
annotated to reflect the number of carbons within their FA chains followed by their level 
of unsaturation. Example MS/MS data of glycerophospholipids and metabolites is 
provided in Figure D.3 and D.4. As observed in the mass spectra, DESI-MS imaging 
revealed differences in the relative abundances of a variety of molecular ions between 
eutopic and ectopic tissues. Within the low mass-to-charge (m/z) range, the most notable 
difference between the two tissue types was the intensity of m/z 126.905, tentatively 
identified as iodide, which was considerably higher in the eutopic endometrial sample  
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Figure 5.1. Negative ion mode DESI-MS imaging data acquired from endometriosis and 
eutopic endometrium tissues obtained from different patients.  
(A) Selected DESI-MS profiles from the endometrial glands within ectopic endometrial 
tissue collected from endometriosis lesions (top) and eutopic endometrial tissue from 
inside the uterus (bottom). The spectra shown are an average of 10 scans. (B) Selected 
DESI-MS ion images of endometriosis and endometrium tissues. Regions of endometrial 
glands and stroma within the lesions are outlined in black on the optical images of the 
H&E stained tissue sections. (C) High magnification view of an endometriosis tissue 
showing outlined regions of endometrial glands and stroma that spatially correlate to the 
distributions of various molecular ions detected by DESI-MS imaging, as exemplified 
by m/z 303. 233 and m/z 723.478 shown. 
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when compared to endometriosis lesions. In the higher m/z range, the most dominant 
peak within the mass spectra for the endometriosis lesions is at m/z 788.544, identified as 
PS 18:1_18:0, whereas the most abundant peak in the eutopic endometrium is at m/z 
885.549, identified as PI 18:0_20:4. 
DESI-MS imaging data obtained from eutopic endometrial tissues typically 
presented a homogenous distribution of molecular ions and thus ion images, reflecting 
the uniform distribution of endometrial glands and stroma within these tissues. In 
contrast, DESI-MS imaging of tissues containing endometriosis lesions yielded more 
heterogeneous images (Figure 5.1B). Upon pathological evaluation of the endometriosis 
tissues, it was determined that areas containing endometrial glands and stroma as small as 
50 µm in size were distributed throughout various tissue types including peritoneum and 
connective stroma. Endometrial glands presented as hollow structures within the tissue 
sections surrounded by endometrial stroma and therefore exhibited no lipid or metabolite 
data. Hemosiderin was also observed with high ion signal intensity in a subset of the 
endometriosis tissue sections analyzed, further contributing to the spatial heterogeneity in 
the ectopic endometrial tissues. As seen in the selected ion images in Figure 5.1B, the 
most intense ion signal observed from various biological molecules in the DESI-MS ion 
images typically correlated to tissue regions that contained endometrial glands and 
stroma, while surrounding connective tissue regions presented low cellular density as 
well as lower ion signal intensity (Figure D.5). Figure 5.1C, for example, shows a higher 
magnification of an endometriosis tissue obtained from the rectum of a patient, in which 
high intensities of m/z 303.233, identified as FA 20:4, and m/z 723.478, identified as CL 
72:8, are observed in tissue regions that spatially overlap with endometrial cells (glands 
and stroma) found within the surrounding serosal connective tissue. There were other 
tissues and cell types distributed throughout the samples obtained, including 
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inflammatory and ovarian cells, that yielded higher intensities of lipids and metabolites 
(Figure D.6) Thus, to assure molecular information from only endometrial cells was 
being evaluated, we relied on pathological determination of endometrial glands and 
stroma to precisely locate regions of endometrial cells within endometriosis lesions tissue 
for comparison to eutopic endometrial tissue. Due to the histological complexity of the 
tissues and the need to precisely identify regions of pure endometrial cells to extract 
molecular information, we applied DESI-MS at a spatial resolution of 100 µm. DESI-MS 
imaging studies using large sample cohorts are often performed at a lower spatial 
resolution, typically between 150–250 µm.187 In our study, a spatial resolution of 200 µm 
was also tested but was not sufficient to clearly define regions of endometrial tissue from 
the surrounding thus, 100 µm was used. 
To evaluate if differences in molecular profiles were potentially related to patient-
to-patient variability, eutopic endometrial tissue as well as ectopic endometriosis tissues 
from various locations within the abdominal cavity were obtained from the same patient 
and compared. One patient, identified as #98, provided an eutopic endometrial sample as 
well as four endometriosis tissues collected from the bladder, rectum, left ovary, and an 
endometrioma. Qualitatively, the trends in molecular profiles detected from eutopic and 
ectopic endometrial tissues from the same patient appeared to follow similar trends as 
described for samples from different patients, including an increased abundance of iodide 
within the eutopic endometrium and higher relative abundance of PS 18:1_18:0 within 
the endometriosis lesions (Figure 5.3A). The molecular patterns detected in 
endometriosis lesions also appeared to be consistent and independent of the organ from 
which the sample was collected. To evaluate and visualize intra-patient molecular 
differences between the eutopic and ectopic endometrial tissues, principal components 
analysis (PCA) was performed on the data collected for these five samples. As observed  
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Figure 5.2. Comparison of 2D DESI-MS ion images of m/z 885.549 of an endometriosis 
lesion tissue section at 200 µm and 100 µm spatial resolution.  
The solvent used for the 200 µm imaging was 1:1 ACN:DMF at 1.2 µL/min, while the 
solvent used for the 100 µm imaging was 3:1 ACN:DMF at 1.4 µL/min. 
 
200 μm spatial 
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Figure 5.3. Intra-patient analysis of eutopic endometrium and four endometriosis tissues 
collected from ovary, rectal, bladder and endometrioma (patient #98).  
(A) Selected DESI mass spectra obtained from three samples, including endometriosis 
from both the right ovary and an ovarian cyst (endometrioma), and eutopic endometrium. 
(B) PCA score plots of the per-pixel data extracted from all endometriosis tissues 
(yellow) versus eutopic endometrium tissue (black). (C) PCA results of the per-pixel data 
extracted from endometriosis tissues per region of excision (ovary in orange; rectal in 
pink, bladder in green, endometrioma in blue) versus eutopic endometrium tissue (black). 
Ellipses are calculated by a one-sigma ellipse (68% probability) of an estimated bivariate 
Gaussian distribution for each group. 
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in Figure 2B, the first two principle components allowed for separation between the data 
obtained from eutopic and ectopic endometrial tissues. Interestingly, separation was also 
observed within the data obtained for endometriosis lesions collected from different 
organs. Similar results were observed from tissues collected from different patients 
(Figure D.7 and D.8) and analysis of eutopic and ectopic endometrium from the same 
patient showed clear differences in the molecular pattern yielded by DESI-MS (Figure 
5.4), thus suggesting that the molecular changes are associated to biological events rather 
than patient-to-patient variability such as diet or environmental factors. 
DESI-MS imaging experiments further revealed a unique mass spectrum in 
specific regions of many endometriosis lesion samples. While this mass spectrum was not 
correlated to any particular histological feature as determined by histopathologic 
evaluation, it appeared to co-localize to regions of blood deposits in the tissue. The mass 
spectra exhibited a unique molecular pattern from any other observed in this study with 
an unusual high relative abundance of ions that are not typically detected from 
mammalian tissues (Figure 5.5). Ions detected in the higher mass region m/z 950–1050 
were identified as n-acylphosphatidylethanolamines (NAPE), rare complex lipids that are 
formed when the amine group on the PE phospholipid headgroup forms an amide bond 
with a fatty acid. NAPE lipids were observed within this unique mass spectrum among 
high abundance of PA, PG, and PI lipids that were also detected throughout the rest of the 
tissue sample although at lower relative abundances. NAPEs constitute about0.01% of 
mammalian cell membranes and are often correlated to cellular stress conditions such as 
ischemia and Parkinson’s disease.188 Previously, NAPE lipids were detected by DESI-MS 
imaging in rat brains tissues that had been subjected to focal brain ischemia, showing the 
slow increase of these lipids in the ischemic area within24 hr of the stroke, suggesting 
that these species accumulated during cell death.189 In our study, these unique molecular  
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Figure 5.4. DESI-MS imaging data for endometriosis lesions and eutopic endometrium 
collected from the same patient. 
 (A) Ion images of endometriosis and endometrial tissue. For the endometriosis lesions, 
the regions of endometrial glands and stroma within the lesions have been outlined in 
black on the H&E stained optical images. (B) Lipid and metabolite profiles for ectopic 
endometrial tissue collected from endometriosis lesions (Top) and eutopic endometrial 






Figure 5.5. Representative DESI-MS spectrum and ion images corresponding to an 
endometriosis lesion tissue section. 
The regions with this unusual molecular profile were characterized by a high abundance 
of PI, PG, and the rare NAPE lipid species. The regions of endometrial glands and stroma 














patterns were observed in areas presenting cautery damage incurred during the 
endometriosis surgery. We thus hypothesize that the cellular damage endured through the 
electrocautery process induced cell death and caused accumulation of NAPEs and other 
phospholipid species within the cauterized tissue regions. The localization of these 
unique mass spectra to areas consisting of blood deposits also suggests the cells affected 
may be related to the vascular system. While very interesting, the accumulation of NAPE 
species detected are likely not causally correlated to the presence or absence of 
endometriosis lesions but rather an external factor and thus were not considered in our 
statistical analysis, although further investigation is needed. 
5.3.2 Statistical classification of endometriosis and eutopic endometrium with lasso 
We next used the lasso statistical method to develop classification models that are 
predictive of the endometrial stroma from endometriosis and eutopic endometrium, 
identified by pathological evaluation after DESI-MS imaging. Please note that we 
analyzed 35 eutopic endometrial samples and 196 endometriosis lesions using DESI-MS 
imaging. However, upon pathological evaluation of the stained tissue sections after DESI 
imaging, only 22 of the 35 eutopic endometrial tissue sections and 76 of the 196 ectopic 
endometriosis samples from 51 patients contained endometrial stroma and were used for 
statistical analysis (Figure 5.6A). A summary of cycle information has been provided for 
patients whose samples were used for statistics in Table D.4. The distribution of 
menstrual cycle information was similar for eutopic endometrial samples and 
endometriosis samples, and thus we do not believe this factor will have a significant 
impact on our statistical analysis. Some patients contributed multiple samples including 
tissues of a variety of endometriosis subtypes as well as eutopic endometrial tissues, as 
described in detail in Table D.1. The MS imaging dataset used for statistical analyses was  
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Figure 5.6. Results of statistical analyses performed on DESI-MS imaging data. 
 (A) A total of 98 tissues including 76 tissues with endometriosis lesions and 22 eutopic 
endometrium tissues were prospectively collected from 51 different patients. (B) Lasso 
per-pixel accuracy results for the training, test, and validation sample sets. (C) Features 
selected by lasso as discriminatory for endometriosis and endometrial tissue, where 
negative weights are more indicative of endometriosis and positive weights are more 
indicative of endometrial tissue. (D) Features selected by bootstrap analysis of the same 
sample set that are indicative of endometriosis or endometrial tissue, where negative z-
scores indicate increase abundance in endometriosis and positive z-scores indicate 





therefore comprised of 28,793 pixels extracted from endometrial glands and stroma 
within 22 eutopic tissues (21,478 pixels) and 76 ectopic tissues (7,315 pixels). 
Considering the large number of molecular species detected, we chose to utilize the lasso 
regularization to construct a logistic regression classifier based on a sparse set of 
features.190 The lasso technique has been previously used to create parsimonious and 
interpretable models with MS imaging data sets that are based on a subset of molecular 
features that effectively differentiate tissue types.177 In our study, the samples were split 
into a training set (n = 59), a validation set (n = 14), and an independent test set (n = 25). 
The training set was used to train the lasso classification model for distinguishing 
endometriosis and eutopic endometrium using five-fold cross validation (CV). 
Optimization of the classifier was performed by optimizing the overall positive percent 
agreement (PPA), negative percent agreement (NPA), and overall accuracy of the 
training and validation sets, while maximizing the number of biological features selected. 
In the training set evaluation, the lasso model provided a PPA of 96.9% and NPA 
of 87.3% for diagnosis of ectopic endometrial tissue, yielding an overall accuracy of 
89.4% per-pixel. To evaluate possible model overfitting, we then applied the model to a 
validation set of samples and achieved 93.8% PPA, 99.2% NPA, and an overall 
agreement of 97.8% per-pixel. Next, we used the model to predict on a withheld, 
independent test set to further evaluate its robustness. The test set prediction yielded 
96.7% PPA, 100% NPA and an overall accuracy of 98.8% per-pixel. Detailed per-pixel 
and per-sample classification results are provided in Table 5.1, and a summary of the per-
pixel results is provided in Fig. 5.6B. On a per-sample basis, where a majority vote from 
pixel classification within a sample determines the sample diagnosis, four samples were 
misclassified: one eutopic endometrial sample from the training set and three ectopic 
endometriosis samples, one from each of the sample sets. Upon further pathologic review 
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Table 5.1. Confusion matrix of the per-pixel and per-patient statistical results provided by 
the lasso model for the training, validation, and test sets of samples.  















Endometriosis 3505 111 96.9 
89.4 
Endometrium 1689 11640 87.3 
Per Sample 
Endometriosis 43 1 97.7 
96.6 













Endometriosis 1248 82 93.8 
97.8 
Endometrium 33 3853 99.2 
Per Sample 
Endometriosis 10 1 90.9 
92.9 






 Per Pixel 
Endometriosis 2290 79 98.8 
98.8 
Endometrium 0 4263 100.0 
Per Sample 
Endometriosis 20 1 95.2 
96.0 
Endometrium 0 4 100.0 
 












of these samples, the misclassified ectopic endometriosis sample from the test set was 
determined to be mesothelium rather than endometriosis. Additionally, the misclassified 
endometriosis sample from the validation set was mixed with hemosiderin tissue. No 
atypical histologic features were found in the misclassified eutopic endometrial sample or 
the misclassified endometriosis sample from the training set. 
A benefit of the lasso logistic regression method is the selection of predictive 
features that contribute most heavily to the classification model. The selected 
endometriosis model consists of 16 tissue specific molecules that allowed for optimal 
differentiation between these tissue types with varying mathematical weights that signify 
their contribution to the model (Figure 5.6C). Note that a total of 18 features were 
selected, but 2 of those were determined to be background peaks and thus not 
biologically relevant. Of the 16 tissue specific features, 5 were selected as indicative of 
endometriosis while 11 were more indicative of eutopic endometrial tissue. A list of the 
selected features, their statistical weights in the model, and their tentative identifications 
are provided in Table 5.2. 
Statistical analyses of the data obtained from eutopic and ectopic endometrial 
tissues from 51 patients allowed for clear differentiation of these two tissue types and 
identification of statistically significant molecular markers, thus indicating occurrence of 
inherent molecular differences between these tissue types despite the histologically 
similar nature of the stromal cells (Figure D.9).191 
5.3.3 Selection of interesting molecular features by bootstrap empirical Bayes 
analysis 
While the lasso logistic regression performs feature selection during the 
construction of the predictive model, it does not necessarily select all features within the 
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Table 5.2. Lasso weight, detected m/z value, proposed identification and mass error for 













 Indicative of endometriosis 
 
215.05* -10.46 215.033  215.0322 Hexose [M+Cl] -2.3 
279.23 -4.07 279.233  279.2330 FA 18:2 -2.1 
281.25 -0.27 281.249  281.2486 FA 18:1 -1.8 
788.54* -10.19 788.544  788.5447 PS 18:1_18:0 -0.1 
 
 Indicative of eutopic endometrium 
 
126.91* 46.34 126.905  126.9045 Iodine [M] -5.5 
187.04* 8.21* 187.041   --‡ -- 
201.04* 6.32 201.038  201.0375 Lactate [2M+Na-2H] -2.5 
255.23 3.01 255.233  255.2330 FA 16:0 [M-H] -2.4 
303.23 0.94 303.233  303.2330 FA 20:4 [M-H] -2.0 
305.26 0.92 305.249  305.2486 FA  20:3 [M-H] -0.3 
331.26 2.67 331.264  331.2643 FA 22:4 [M-H] -1.8 
421.22 0.55 421.226  421.2260 Dioctyl sulfosuccinate [M-H] -1.9 
479.36 3.79 479.356   -- -- 
885.56 0.19 885.549  885.5499 PI 18:0_20:4 [M-H] -1.0 
887.56 20.34 887.557  887.5566 PI 18:0_20:3 [M-H]  -0.5 
‡ Indicates isotope. 
Features that were also selected by the nonparametric bootstrap analysis are denoted with 
an *. Features without a proposed identification, denoted by a – in the “Identification” 
column, are of unknown origin and may not be biologically relevant, but have been 
included for transparency.  
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data set that are significantly different between the two groups if these features do not 
improve the classification performance. Judging by the out-of-sample predictive accuracy 
of the final selected lasso model, there appears to be a large number of signals present to 
distinguish the two groups. Because lasso favors parsimony, the final selected set of 
features likely does not fully encompass the molecular differences between the groups. 
To more comprehensively evaluate these molecular differences between eutopic 
and ectopic endometrial tissues, we next performed a nonparametric bootstrap analysis 
using the same extracted data used for the lasso analysis. Here the goal is to search for 
features that are marginally different in abundance between the groups rather than to 
build a parsimonious predictive model. As nearly all features were found to be 
statistically significantly different in mean intensity between the two groups (Figure D.1), 
with p-values nearly all approximately zero, we carried out an empirical Bayes analysis 
to find the most “interesting” features, or those that are outliers when compared to the 
entire population of features in terms of difference in mean intensities.185 We hypothesize 
that each feature is either “uninteresting” or “interesting,” and each of these two groups 
of features has a corresponding distribution of test statistics, the null and alternative 
distributions, respectively. Once these distributions are estimated, as illustrated in Figure 
D.2, we calculate the posterior probability of each feature being in the “interesting” group 
of features. We set the target false discovery rate to 20%, yielding the selection of 49 
features, 37 of which were determined to be tissue specific (Figure 5.6D). A list of tissue 
specific selected features, along with their z-scores, posterior probabilities, and tentative 




Table 5.3. Z-score, detected m/z value, proposed identification and mass error for the 










Increased abundance in endometriosis 
168.04 -44.10 168.031 168.0297 2-furoylglycine [M-H] § -4.8 
187.01 -53.32 187.007 187.0065 P-Cresol Sulfate [M-H] § -3.7 
215.05* -55.17 215.033 215.0322 Hexose [M+Cl] -3.7 
216.03 -38.29 216.036 216.0356 Hexose [M+Cl] ‡ -3.2 
217.03 -52.88 217.030 217.0293 Hexose [M+Cl] ‡ -2.3 
254.08 -71.44 254.079 -- -- -- 
323.23 -54.93 323.220 323.2198 MG 14:0 [M+Na-2H]§ -0.6 
377.09 -39.09 377.085 377.0851 Disaccharide [M+Cl] -1.3 
701.52 -72.69 701.512 701.5127 PA 18:1_18:0 [M-H] -0.4 
702.51 -70.29 702.516 702.5161 PA 18:1_18:0 [M-H+1]‡ -0.1 
760.52 -77.71 760.512 760.5134 PS 16:0_18:1 [M-H] -0.5 
761.52 -55.92 761.517 761.5168 PS 16:0_18:1 [M-H+1]‡ -0.8 
771.52 -36.15 771.518 771.5182 PG 18:1_18:2 [M-H] -1.8 
773.53 -36.72 773.533 773.5338 PG 18:1_18:1 [M-H] -3.6 
788.54* -70.31 788.544 788.5447 PS 18:0_18:1 [M-H] -0.1 
789.55 -67.87 789.547 789.5481 PS 18:0_18:1 [M-H+1]‡ -0.3 
790.55 -67.87 790.550 790.5514 PS 18:0_18:1 [M-H+2]‡ -0.5 
791.55 -52.22 791.552 791.5548 PS 18:0_18:1 [M-H+3]‡ -0.8 
810.53 -36.11 810.528 810.5291 PS 18:0_20:4 [M-H] -0.6 
811.532 -36.04 811.532 811.5326 PS 18:0_20:4 [M-H+1]‡ -0.6 
844.61 -39.92 844.607 844.6073 PS 18:1_22:0 [M-H] -1.2 
845.61 -39.26 845.611 845.6107 PS 18:1_22:0 [M-H+1]‡ -1.1 
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Increased abundance in eutopic endometrium 
 
124.01 69.70 124.008 124.0068 Taurine [M-H] -6.5 
126.91* 285.56 126.905 126.9045 Iodine [M] -5.5 
151.03 100.60 151.026 151.0256 Xanthine [M-H] -5.3 
186.05 130.60 186.046 -- -- -- 
187.04* 129.78 187.042 -- --‡ -- 
188.06 114.72 188.062 -- -- -- 
189.05 90.63 189.058 -- --‡ -- 
201.04* 71.70 201.038 201.0375 Lactate [2M+Na-2H] -2.0 
307.27 84.25 307.264 307.2643 FA  20:2 [M-H] -1.6 
308.26 69.88 308.268 308.2675 FA 20:2 [M-H+1]‡ -1.3 
309.29 77.48 309.280 309.2799 FA 20:1 [M-H] -1.3 
333.27 79.55 333.280 333.2799 FA 22:3 [M-H] -0.3 
341.23 74.55 341.225 341.2245 FA 20:3 [M+Cl] -3.8 
365.34 73.80 365.343 365.3420 Tetracosanedione [M-H] -1.6 
‡ Indicates isotope 
§ Identified with exact mass alone due to low abundance or interference with other 
species 
 
Features that were also selected by the lasso analysis are denoted with an *. Features 
without a proposed identification, denoted by a – in the “Identification” column, are of 






Table 5.3. (cont.) 
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5.3.4 Biological significant of features selected by lasso and empirical bootstrap 
analyses 
Lasso and bootstrap empirical Bayes analyses allowed identification of 53 tissue 
specific features as important in characterizing endometriosis and eutopic endometrial 
tissue. Note that six features were selected by both the lasso and the bootstrap and are 
noted in Tables 5.2 and 5.3. Additionally, the models selected 13 values that were 
isotopes of already selected molecular ions and were excluded from the final number of 
features. Therefore, the total number of distinct molecular features selected by both 
methods not including duplicates or isotopes is 34. Evaluation of the ions selected 
revealed trends in the molecular information that may give insights into the biological 
processes occurring in these tissues. Interestingly, fatty acids play a significant role in our 
models; shorter acyl chain FA (FA 18:1 and FA 18:2) were more characteristic of 
endometriosis tissue while longer fatty acid chains with higher levels of unsaturation (FA 
20:2, FA 20:3, FA 20:4, FA 22:3, and FA 22:4) were more characteristic of eutopic 
endometrium. Previous studies have evaluated the effect of polyunsaturated FA, and 
more specifically omega-3 FA, on the survival of endometrial cells in culture and 
determined that the presence of certain highly saturated fatty acids suppressed 
endometrial cell survival. Similarly, serum from women with endometriosis was found to 
have lower levels of the same polyunsaturated FA, eicosapentaenoic acid (FA 20:5), than 
the serum of healthy controls.192 While FA 20:5 was detected at very low relative 
abundance at m/z 301.217 by DESI-MS imaging, a number of polyunsaturated FA with 
the same acyl chain length were selected as indicative of eutopic endometrium. While we 
are currently unable to determine if the polyunsaturated FA within our data are omega-3 
fatty acids due to inability of traditional MS fragmentation methods to determine double 
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bond position, this strengthens the hypothesis that highly unsaturated FA may be at 
decreased levels in endometriosis lesions. 
Studies have suggested that molecular events related to dysregulated phospholipid 
and sphingolipid metabolism play a role in endometriosis pathogenesis.160,165,169,170,193-195 
In particular, glycerophosphocholine (PC) species have been detected at altered levels in 
biological specimens from endometriosis patients when compared to healthy 
controls.169,193-195 For example, Vouk et al. found the upregulation of 5 PC lipids in the 
serum of patients with endometriosis but later found 4 different PC species 
downregulated in the peritoneal fluid of endometriosis patients compared to controls. 
Most of these studies were performed using MS in the positive ion mode, in which 
zwitterionic PC, sphingomyelins, and PE lipids are more easily detected, while our study 
was performed in the negative ion mode, which favors detection of phospholipids with 
negatively charged headgroups. A previous study reported higher abundance of a 
potassium adducted PS species within the follicular fluid of control patients compared to 
patients with endometriosis.165 In contrast, multiple PS species including PS 16:0_18:1, 
PS 18:1_18:0, PS 18:0_20:4, and PS 18:1_22:0 were selected as indicative of 
endometriosis tissue rather than eutopic endometrium in our statistical models. PS are 
typically confined to the inner membrane of eukaryotic cells but are known to be 
involved in multiple cellular processes including homeostasis and programmed cell 
death.196 The upregulation of PS in endometriosis lesions could be a result of increased 
blood coagulation of the endometrial tissue during or after a woman’s menstrual cycle, 
when the endometrial lining within the uterus is expelled from the body due to a decrease 
in estrogen levels. Endometriosis tissues respond similarly to hormonal levels but are 
trapped within the adhesions, which could potentially signal coagulation cascades, 
triggering exposure of PS on the outer surface of blood platelets.197 In addition to PS, 
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multiple PA and PG species were selected by the bootstrap empirical Bayes analysis as 
having increased relative abundance within the ectopic endometriosis tissue while PI 
18:1_20:4 was selected as a feature more indicative of eutopic endometrium. 
A variety of small metabolites were also selected as features within our models 
for endometriosis and eutopic endometrium. For example, hexose, presumed to be 
glucose due to its abundance within tissue, was selected in its chlorine adducted form as a 
feature indicative of endometriosis lesions in both models. Previous studies have shown 
alterations in the glucose transporter proteins in the eutopic endometrium of women with 
endometriosis and their matching endometriosis lesions, likely associated to different 
glucose uptake between these cell types.198 As expected from qualitative evaluation of the 
mass spectra, iodine was also selected as a feature indicative of eutopic endometrium in 
both our statistical analyses. The presence of this ion within the eutopic endometrium 
may be related to the proximity of this tissue to the cervix which is known to contain a 
high concentration of iodine when compared to other body areas.199 Additionally, some 
research studies also suggest that endometriosis is an iodine-deficiency disease and thus 
would account for the lower levels of iodine within the ectopic endometrium detected in 
our study.200 An ion at m/z 246.951 was also selected by both the lasso and the 
nonparametric bootstrap models as indicative of endometriosis. Interestingly, an ion at 
m/z 246.951 has been previously visualized in other DESI-MS imaging studies and 
suggested a potential indicator of normal tissue when compared to squamous cell 
carcinoma and lung adenocarcinoma tissues.201 Based on tandem MS (Figure D.10) and 
exact mass measurements, we identified m/z 246.951 as a heavily fluorinate compound 
with the molecular formula C3HF6SO4. Due to the fluorinated nature of this compound, 
we hypothesize that this ion corresponds to a drug metabolite from the breakdown of the 
surgical anesthetic commonly used during endometriosis surgery, rather than an 
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endogenous molecule. Its presence within our statistical models, while undesirable, is not 
unexpected considering the untargeted nature of MS imaging analyses and emphasizes 
the importance of retroactive investigation of the molecules selected by the statistical 
models using these data sets. Due to its exogenous nature, we have removed this feature 
from the list of tissue-specific features shown in Tables 5.2 and 5.3. 
 
5.3.5 Clustering of endometriosis lesions by disease subtype 
Our statistical analyses were performed under the assumption that all 
endometriosis lesions would have similar molecular patterns. However, endometriosis 
subtypes characterized by region of excision may contribute to heterogeneity within the 
collective data, as suggested by our intra-patient analyses. Endometriosis lesions may be 
separated into three categories: ovarian, peritoneal, and deep infiltrating endometriosis, 
depending on where the lesion was located within the body.202 Researchers have 
suggested that these categories should be treated as separate entities with potentially 
different causes, symptoms, and treatments.175  To address the potential for heterogeneity 
due to lesion subtype, PCA was performed on all the ectopic endometrium. Figure 5.7 
shows the PCA results, with different colors representing different tissue subcategories 
based on their location within the patients. No separation was seen based on 
endometriosis subcategory, with extensive amount of data overlap. Further, when 
faceting the PCA score plot to isolate pixels originating from the same patient sample 
(Figure D.11), any clustering observed could be attributed to data from the same tissue 
sample and not subtypes, an observation that was not surprising considering biological 
variance between patients. These results suggest that the molecular data acquired by 
DESI-MS imaging in this study does not allow for subtyping based on tissue location  
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Figure 5.7. PCA score plot of ectopic endometrial tissue, grouped by region of excision, 













across different patients. This observation is also partially supported by the high 
predictive accuracy achieved by our lasso model in which the data were collectively 
combined into a single endometriosis class. 
5.5 CONCLUSIONS 
DESI-MS imaging was used to investigate the spatial distribution and metabolic 
profiles of the eutopic endometrium and endometrial stroma from endometriosis lesions. 
While greatly less metabolic coverage is achieved with DESI-MS imaging than 
traditional MS techniques such as LCMS, the spatial resolution provided by DESI-MS 
imaging (100 µm) allowed collection of spatially-resolved metabolic information and 
showcase the usefulness of MS imaging in segregating endometriosis lesions within 
complex tissues. Despite being histologically similar, DESI-MS imaging and statistical 
analyses allowed identification of distinct chemical differences between the two tissue 
types, which could be indicative of biological changes associated with differences 
between eutopic endometrium and endometriosis lesions. While the biological processes 
that may be driving these differences are unclear, our results suggest that metabolic 
differences between these two tissue types exist which could potentially be translated to 
future discoveries of clinical biomarkers of endometriosis. However, it remains a 
possibility that these differences between eutopic and ectopic endometrium are due to 
their immediate environment rather than inherent differences between eutopic and ectopic 
endometrial tissues. Further, as patients on hormonal treatment were included in our 
study to maximize sample accrual, metabolic alterations due to hormonal treatment, as 
previously observed in plasma and serum,203,204 could have potentially affected the results 
obtained in our analyses. Although inclusion of tissues from patients on hormonal 
treatment is a limitation of our study, statistical analysis of the data obtained from tissues 
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of patients both on and off hormonal treatment for endometriosis should allow selection 
of metabolic markers that occur within both groups, independent of hormonal treatment. 
Further studies are planned to evaluate metabolic changes in tissues from endometriosis 
patients depending on hormonal treatment. Additionally, our study does not determine if 
the eutopic endometrium from endometriosis patients is molecularly similar to eutopic 
endometrium from healthy women, as these samples were not available for our study. 
Future studies to validate and elaborate these findings, including integration of healthy 
controls, symptom correlation to specific molecular features, and evaluation of other 




Chapter 6: Conclusions and Perspectives 
 Throughout the last two decades, ambient ionization MS methods have proved to 
be excellent tools for the molecular characterization of biological samples in situ, 
revolutionizing the way in which MS can be used in a clinically relevant context. By 
allowing for analysis of metabolites, lipids, and proteins directly from clinical specimens, 
including tissue biopsies, we are closer than ever to being capable of monitoring 
biological alterations due to disease in real time without harm to patients. However, there 
remains limitations in ambient ionization techniques that have yet to be fully addressed, 
preventing further adoption of these technologies outside of an academic setting. The 
goal of this dissertation was to begin addressing some of these constraints and provide 
insights into potential avenues for continued advancement so that these technologies may 
one day be used for the improvement of patient care.  
Reliability and consistent performance of technologies used for clinical research 
applications is of the utmost importance as clinicians rely on accurate and timely results 
to administer appropriate treatment and ensure positive outcomes for their patients. As 
with any new methodology, ambient ionization MS techniques must be rigorously tested 
and validated to ensure that data quality to maintained in a variety of situations. As 
alluded to in chapter two, the environmental factors that influence the performance and 
reliability to ambient ionization MS technologies have not been fully explored. Our 
results suggest that DESI-MS data quality and consistency fluctuate with relative 
humidity, a previously unexplored factor in the field. As the sampling and ionization of 
analytes occurs in the open atmosphere for ambient ionization techniques, environmental 
factors such as relative humidity in addition to temperature, elevation, and ambient air 
flow may be overlooked variables that need to be controlled. Systematic evaluation of 
these parameters, as was performed for changes in relative humidity described here, 
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could reveal insights into the environmental conditions necessary to obtain optimal 
results when performing ambient ionization MS on biological tissue samples.  
Additionally, to ensure these technologies are robust and can be relied upon despite 
alterations in the environment, larger studies performed at multiple sites that include a 
variety of patient populations must be completed. Differences between healthy and 
diseased tissue must be large enough to overcome intra-laboratory variable that will be 
present if these technologies are applied on a larger scale. While some multicenter studies 
evaluating the performance of ambient ionization techniques for disease discrimination 
have been performed,22 a stronger emphasis must be placed on this fact in future work to 
prove these technologies can truly be applied for clinical problems. 
Further advances in the field of ambient ionization MS will most likely be 
focused on increasing the breadth of information that can be obtained with these 
technologies. Two approaches towards this objective were discussed within this 
dissertation. The first was to improve the detection of molecules that are typically 
detected in low abundance from biological samples by integrating ambient ionization 
with gas-phase separation techniques. As discussed in chapter three, coupling of a 
FAIMS separation to both DESI and LMJ-SSP MS facilitated the detection of an 
increased number and intensity of large, multiply charged biomolecules directly from 
human tissue. However, this improvement in detection comes with the disadvantage of 
decreased overall ion signal intensity due to the filtering of ions prior to mass analysis. 
As many ambient ionization MS methods already suffer from low ion signal intensity, 
further reduction of the ion abundance is not ideal for many applications. Improvements 
in sensitivity of mass spectrometers could alleviate some of the effects from this signal 
reduction, increasing the number of applications that could benefit from FAIMS 
separation prior to analysis. Improved mass spectrometers have allowed for 7 to 10-fold 
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increases in the number of protein species detected from biological tissue sections when 
coupled liquid extraction ambient ionization techniques, and even further improvements 
were observed with the addition of FAIMS.205 Increases in the sensitivity of mass 
spectrometers will allow for the use of ambient ionization techniques in a wider variety of 
biological applications where sensitivity is an issue. Additionally, while current ion 
mobility methods allow for gas phase separation of ions to achieve some level of 
chromatographic separation, the efficiency of these separations is far below that of what 
can be achieved using more traditional liquid chromatography methods. Further 
improvements in the separation capabilities of ion mobility technologies would be a 
significant advancement for the field, particularly if they could allow for the separation of 
isobars and isomers. Recently, advancements have been made in ion mobility technology 
that allows for separation of some lipid and peptide isomers with promising results.206-208 
These high-resolution ion mobility systems have yet to be coupled to imaging modalities 
and have not been applied for the analysis of samples with extremely complex matrices 
such as tissue sections, but their potential for integration with ambient ionization 
technologies remains an intriguing avenue for future studies. 
Another method for increasing the amount of available information yielded during 
an MS imaging experiment is to perform fragmentation of an analyte of interest to 
determine if isomers are present at the same exact mass. As discussed in chapter 4 of this 
dissertation, tandem MS imaging that can uncover structural information regarding the 
molecules within a tissue sample can yield new insights into the dysregulation of cellular 
pathways occurring in diseased tissue. Fragmentation by UVPD has shown particularly 
useful due to its ability to produce fragments that are diagnostic of structurally relevant 
components of lipids that traditional collision-based activation methods do not provide. 
Through the integration of UVPD and DESI-MS imaging we have been successful in the 
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imaging of lipid isomers within several types of biological tissue sections, allowing for 
in-depth analysis of double bond positioning differences between normal and cancerous 
tissue as well as between cancer tissue subtypes.135 Limitations in this technique, 
however, prevent application to large sample sets. For example, the combination of the 
low sensitivity of DESI-MS analyses and the inherent inefficiencies in UVPD 
fragmentation prevents analysis of lower abundance molecules within tissue samples and 
requires longer analysis times in order to obtain adequate signal for reliable double bond 
diagnostic information. This limits the number of ions that can be analyzed for double 
bond information. Additionally, the software that is currently available for MS imaging 
applications does not facilitate the separation of multiple tandem MS events during one 
experiment, thus preventing evaluation of multiple transitions simultaneously. Therefore, 
to investigate multiple lipids from one tissue sample replicate tissue sections need to be 
analyzed, greatly lengthening analysis time and preventing analysis of multiple molecules 
from the same cell populations. Despite these drawbacks, DESI-UVPD-MS imaging of 
tissue sections is one of a few tools that can allow for spatially resolved imaging of 
isomer distributions within a sample and limitations could be addressed with 
improvements in instrument performance and development of software programs capable 
of separating tandem MS events for imaging applications. 
Since their invention in 2004, ambient ionization MS technologies have shown 
usability in a variety of fields but none more so than for use in clinical applications. Their 
ability to be implemented in many environments without need for high vacuum sample 
chambers and lengthy sample preparation steps spurred researcher that could one day be 
performed at hospitals and clinics. Cancer diagnostics, for example, has been an area of 
intense investigation with ambient ionization MS, with applications such as breast22,209, 
thyroid27,28,209, and ovarian cancers25,51, among others, being explored within the last few 
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years.  However, applications outside of oncology that have heterogenous tissue 
morphology could also be explored with MS imaging technologies. As described in 
Chapter 5 of this dissertation, DESI-MS imaging was applied for the investigation of 
metabolic alterations occurring in association with endometriosis. As endometriosis 
lesions are heterogeneously complex, DESI-MS imaging allowed for spatial targeting of 
the endometrial cells within the lesions and healthy endometrium tissue. This enabled the 
development of molecular classifiers that were built using pure cellular environments for 
direct comparison of these two tissue classes. DESI-MS data collected allowed for 
excellent distinction between the eutopic and ectopic endometrium tissue and for the 
identification of statistically significant differences in the metabolite and lipid 
abundances. Further work is needed to verify these alterations are biologically 
significant, however, as DESI-MS is typically used as a discovery tool and is not a 
quantitative technique. Imaging of the protein alterations between these two tissues 
would allow for an increased understanding of the exact biological pathways that may be 
dysregulated in endometriosis lesions. While DESI-MS imaging of proteins has recently 
been shown210,211, analysis of less abundant protein molecules requires analysis with 
other MS technologies such as MALDI-MS. Additionally, the use of MALDI-MS would 
enable even higher spatial resolution during imaging experiments, potentially allowing 
for the investigation of lipid and metabolite alterations within endometrial glands that can 
be as small at 20µm. Further analysis of endometriosis stroma from ectopic and eutopic 
endometrium with quantitative MS techniques, such as LCMS, would also be a valuable 
exercise to verify metabolic markers selected in this work are significantly altered. These 
future studies are necessary to continue exploring if MS technologies can yield insights 
into disease pathogenesis and suggest potential therapeutic targets for disease 
management. 
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MS technologies, specifically ambient ionization MS techniques, have the 
potential to significantly disrupt the diagnostic space with potential applications both in 
and out of the clinic. As these techniques advance and methods are developed to tackle 
complex problems facing patients and health care professionals, MS will inevitably 
become an integral part of many clinical workflows due to the potential benefits these 
technologies will provide. This dissertation serves as a summary of a small subset of 
work being done in pursuit of implementation ambient MS methods in a wide variety of 
healthcare applications. Despite the challenges that remain, strides are being made 
throughout the field to make ambient ionization tools robust and versatile for routine use 
to facilitate and improve patient care.  
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APPENDIX A: SUPPORTING MATERIAL TO ACCOMPANY CHAPTER 2 
 
 
Figure A.1. Voltage vs relative standard deviation of the total ion count at both stable 
(RH 55%) and unstable (RH 20%) conditions.  
The TIC RSD and error bars were determined with using an average of 9 groups of 5 
scans from a DESI-MS line during mouse brain tissue analysis. The RSD of the TIC is 








Figure A.2. TIC chromatogram and average spectrum from mouse brain tissue at low 




Figure A.3. DESI mass spectra from a mouse brain tissue section at low and high voltage 
(low RH, 15-30%) 
Adjusting the voltage to 0 kV during times of low humidity/unstable DESI-MS improves 
the signal stability but reduces the overall ion signal intensity when compared to typical 



















Figure A.5. Representative spectra of DESI-MS of mouse brain in the positive ion mode 
at both high and low humidity. 
There is little difference in the spectra based on the change in humidity in the positive ion 
mode. However, there is a slight improvement in the signal intensity and RSD at low 
humidity, suggesting potential RH dependence at different RH levels than that which is 




APPENDIX B: SUPPORTING MATERIAL TO ACCOMPANY CHAPTER 3 
 
 
Figure B.1. Time-dependent decay of DESI signal for analysis of five representative 
spots for 6 seconds (0.10 min) each, without FAIMS sweep, and an average 













































Figure B.4. Molecular weights of all protein, proteoforms, and protein fragment species 
detected during LMJ-SSP-MS and LMJ-SSP-FAIMS-MS profiling 







Figure B.5. MS/MS of ion cluster at m/z 857.46 from a rat brain tissue section, identified 
at ubiquitin.  
The sequence coverage map of the fragments compared to the sequence of rat ubiquitin is 








Fragments Explained 51% 
Residue Cleavages 32% 
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Table B.1. Matching fragment ions identified from MS/MS of ion m/z 857.46 compared 
with the sequence of rat ubiquitin. 
Name 
Ion 





B2 B 259.0991 259.0979 -0.0012 -4.50 
B9 B 1061.5943 1061.5898 -0.0045 -4.28 
B12 B 1347.7584 1347.7525 -0.0060 -4.43 
B14 B 1561.8902 1561.8900 -0.0002 -0.11 
B16 B 1804.0168 1804.0102 -0.0066 -3.68 
B17 B 1903.0852 1903.0795 -0.0058 -3.02 
B18 B 2032.1278 2032.1188 -0.0090 -4.43 
Y11 Y 1233.7669 1233.7614 -0.0055 -4.46 
Y12 Y 1320.7990 1320.7936 -0.0054 -4.05 
Y13 Y 1449.8416 1449.8362 -0.0054 -3.71 
Y14 Y 1577.9365 1577.9304 -0.0062 -3.90 
Y15 Y 1705.9951 1705.9890 -0.0061 -3.58 
Y16 Y 1819.0792 1819.0727 -0.0065 -3.56 
Y18 Y 2096.1854 2096.1764 -0.0090 -4.28 
Y24 Y 2725.4987 2725.4858 -0.0129 -4.74 
Y28 Y 3210.7109 3210.6945 -0.0164 -5.09 
Y37 Y 4252.3192 4252.3007 -0.0185 -4.35 
Y39 Y 4464.3989 4464.3809 -0.0180 -4.02 
Y40 Y 4561.4517 4561.4344 -0.0173 -3.78 
Y44 Y 4988.6947 4988.6763 -0.0185 -3.70 
Y53 Y 6014.2453 6014.2261 -0.0192 -3.18 
Y54 Y 6127.3293 6127.3034 -0.0259 -4.23 
Y56 Y 6343.4040 6343.3750 -0.0290 -4.56 
Y57 Y 6430.4360 6430.3867 -0.0493 -7.67 
Y58 Y 6527.4887 6527.4705 -0.0183 -2.79 
Y59 Y 6656.5313 6656.5028 -0.0286 -4.29 








Fragments Explained 2% 
Residue Cleavages 43% 
Figure B.6. MS/MS of ion cluster at m/z 828.06 from a rat brain tissue section, identified 
as thymosin β-4.  
The sequence coverage map of the fragments compared to the sequence of rat thymosin 








Table B.2. Matching fragment ions identified from MS/MS of ion m/z 828.09 compared 
with the sequence of rat thymosin β-4. 







B13 B 1547.6813 1547.6796 -0.0017 -1.13 
B18 B 2132.0823 2132.0792 -0.0031 -1.45 
B19 B 2260.1773 2260.1721 -0.0052 -2.28 
B24 B 2848.4164 2848.4143 -0.0021 -0.72 
B25 B 2976.5114 2976.5076 -0.0037 -1.24 
B26 B 3090.5543 3090.5502 -0.0041 -1.33 
B33 B 3842.9611 3842.9526 -0.0085 -2.21 
B34 B 3956.0452 3956.0396 -0.0055 -1.40 
B35 B 4085.0878 4085.0722 -0.0156 -3.82 
B38 B 4470.2839 4470.2757 -0.0082 -1.83 
B39 B 4598.3425 4598.3371 -0.0053 -1.16 
B40 B 4669.3796 4669.3695 -0.0101 -2.16 
B41 B 4726.4011 4726.3878 -0.0133 -2.81 
B42 B 4855.4436 4855.4401 -0.0036 -0.74 
Y15 Y 1659.7951 1659.7926 -0.0025 -1.51 
Y18 Y 1983.9749 1983.9731 -0.0018 -0.90 
Y32 Y 3674.9002 3674.8946 -0.0057 -1.54 
Y40 Y 4588.3217 4588.3140 -0.0077 -1.68 
Y41 Y 4716.4167 4716.4102 -0.0065 -1.37 





Fragments Explained 5% 
Residue Cleavages 21% 
Figure B.7. MS/MS of ion cluster at m/z 845.27 from a rat brain tissue section, identified 
as hemoglobin-α subunit.  
The sequence coverage map of the fragments compared to the sequence of rat 
hemoglobin-α subunit is shown, as well as the ProSight Lite scores. 
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Table B.3. Matching fragment ions identified from MS/MS of ion m/z 845.27 compared 
with the sequence of rat hemoglobin-α subunit. 









B8 B 829.4181 829.4205 0.0024 2.86 
B46 B 5069.4592 5069.449 -0.0099 -1.94 
B73 B 7720.8735 7720.8734 -5.9E-05 -0.01 
B75 B 7964.9430 7964.9293 -0.014 -1.71 
B79 B 8303.1384 8303.1228 -0.015 -1.87 
B106 B 11387.8078 11387.7304 -0.077 -6.79 
B106 B 11387.8078 11387.7884 -0.019 -1.71 
B107 B 11486.8763 11486.8228 -0.053 -4.65 
B107 B 11486.8763 11486.8471 -0.029 -2.53 
B133 B 14221.1758 14221.0836 -0.092 -6.48 
Y11 Y 1239.6823 1239.6800 -0.0022 -1.81 
Y12 Y 1310.7194 1310.7172 -0.0023 -1.71 
Y13 Y 1423.8045 1423.8012 -0.0023 -1.60 
Y14 Y 1570.8719 1570.8706 -0.0013 -0.82 
Y23 Y 2521.3362 2521.3314 -0.0048 -1.91 
Y28 Y 3038.5535 3038.5492 -0.0043 -1.41 
Y29 Y 3175.6124 3175.6062 -0.0062 -1.96 
Y30 Y 3312.6713 3312.6636 -0.0077 -2.32 
Y32 Y 3486.7176 3486.7128 -0.0048 -1.36 
Y33 Y 3599.8017 3599.8019 0.00025 0.06 
Y34 Y 3700.8494 3700.8443 -0.0050 -1.36 
Y35 Y 3799.9178 3799.9160 -0.0018 -0.47 
Y36 Y 3913.0018 3912.9958 -0.0060 -1.53 
Y37 Y 4026.0859 4026.0804 -0.0055 -1.37 
Y47 Y 5198.6660 5198.6481 -0.0178 -3.42 
Y56 Y 6268.2804 6268.2624 -0.0180 -2.87 
Y57 Y 6383.3074 6383.2929 -0.0144 -2.26 
Y59 Y 6583.4235 6583.3645 -0.0590 -8.95 
Y59 Y 6583.4234 6583.3673 -0.0561 -8.52 
Y60 Y 6684.4711 6684.4460 -0.0251 -3.75 
Y61 Y 6771.5032 6771.4669 -0.0363 -5.36 
Y62 Y 6884.5872 6884.5709 -0.0164 -2.37 
Y65 Y 7109.6986 7109.6811 -0.0175 -2.45 
Y92 Y 9817.1390 9817.1061 -0.0329 -3.35 
Y93 Y 9904.1711 9904.1246 -0.0465 -4.69 
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Fragments Explained 50% 
Residue Cleavages 13% 
Figure B.8. MS/MS of ion cluster at m/z 857.96 from an ovarian tumor tissue section, 
identified at ubiquitin.  
The sequence coverage map of the fragments compared to the sequence of human 






Table B.4. Matchi.ng fragment ions identified from MS/MS of ion m/z 952.52 compared 
with the sequence of rat ubiquitin 
 





Y12 Y 1320.7990 1320.7944 -0.0046 -3.48 
Y13 Y 1449.8416 1449.8371 -0.0045 -3.08 
Y14 Y 1577.9365 1577.9314 -0.0051 -3.22 
Y15 Y 1705.9951 1705.9895 -0.0056 -3.30 
Y18 Y 2096.1854 2096.1789 -0.0065 -3.12 
Y24 Y 2725.4987 2725.4897 -0.0090 -3.31 
Y37 Y 4252.3192 4252.3037 -0.0155 -3.63 
Y40 Y 4561.4517 4561.4315 -0.0202 -4.42 
Y57 Y 6430.4360 6430.4162 -0.0197 -3.068 
Y58 Y 6527.4887 6527.4627 -0.0260 -3.99 








Fragments Explained 0% 
Residue Cleavages 12% 
 
Figure B.9. MS/MS of ion cluster at m/z 933.50 from an ovarian tumor tissue section, 
identified as thymosin β-4.  
The sequence coverage map of the fragments compared to the sequence of human 





Table B.5. Matching fragment ions identified from MS/MS of ion m/z 933.50 compared 
with the sequence of human thymosin β-4. 
 
Name Ion Type 
Theoretical 





B9 B 1028.4484 1028.4410 -0.0074 -7.21 
B40 B 4669.3796 4669.3607 -0.0188 -4.03 
B42 B 4855.4436 4855.4379 -0.0057 -1.17 
Y40 Y 4588.3217 4588.3141 -0.0076 -1.65 
Y41 Y 4716.4167 4716.4187 0.0020 0.42 










Fragments Explained 2% 
Residue Cleavages 26% 
Figure B.10. MS/MS of ion cluster at m/z 946.31 from a rat brain tissue section, 
identified as hemoglobin-α subunit.  
The sequence coverage map of the fragments compared to the sequence of rat 




Table B.6. Matching fragment ions identified from MS/MS of ion m/z 946.31 compared 
with the sequence of human hemoglobin-α subunit. 
 





B20 B 2030.1061 2030.1035 -0.0026 -1.264 
B21 B 2101.1432 2101.1404 -0.0028 -1.34 
B27 B 2707.3717 2707.3642 -0.0075 -2.78 
B45 B 4874.4642 4874.4595 -0.0047 -0.96 
B46 B 5021.5326 5021.5280 -0.0046 -0.92 
B47 B 5136.5595 5136.5548 -0.0047 -0.91 
B61 B 6551.3388 6551.3535 0.0147 2.24 
B62 B 6650.4072 6650.3999 -0.0073 -1.10 
B63 B 6721.4444 6721.4323 -0.0120 -1.78 
B64 B 6836.4713 6836.4537 -0.0176 -2.57 
B67 B 7121.6401 7121.5968 -0.0433 -6.08 
B72 B 7613.8846 7613.8668 -0.0178 -2.34 
B73 B 7712.9530 7712.9369 -0.0161 -2.09 
B75 B 7943.0069 7942.9961 -0.0108 -1.35 
B76 B 8074.0474 8074.0317 -0.0157 -1.94 
B78 B 8285.1431 8285.1516 0.0086 1.03 
B79 B 8356.1802 8356.1595 -0.0207 -2.47 
B94 B 10012.0909 10012.0861 -0.0048 -0.48 
B106 B 11376.8547 11376.8189 -0.0359 -3.15 
B109 B 11690.0549 11690.0228 -0.0321 -2.74 
B112 B 11969.1880 11969.1629 -0.0251 -2.09 
B113 B 12082.2721 12082.2634 -0.0087 -0.72 
B116 B 12379.4045 12379.4518 0.0473 3.82 
Y11 Y 1239.68230 1239.6811 -0.0011 -0.92 
Y12 Y 1310.71941 1310.7178 -0.0016 -1.19 
Y14 Y 1570.87188 1570.8688 -0.0031 -1.97 
Y20 Y 2222.20589 2222.2096 0.0037 1.67 
Y23 Y 2489.36417 2489.3615 -0.0026 -1.05 
Y28 Y 3034.61272 3034.6095 -0.0032 -1.04 
Y29 Y 3147.6968 3147.6990 0.0022 0.69 
Y30 Y 3284.7557 3284.7497 -0.0059 -1.81 
Y47 Y 5104.7939 5104.7913 -0.0026 -0.50 




Table B.6. (cont.) 
Y58 Y 6376.4673 6376.4641 -0.0032 -0.50 
Y59 Y 6489.5514 6489.5603 0.0089 1.38 
Y60 Y 6560.5885 6560.5929 0.0044 0.67 
Y61 Y 6647.6205 6647.6159 -0.0046 -0.70 
Y68 Y 7403.9318 7403.9260 -0.0058 -0.78 
Y71 Y 7711.0962 7711.1057 0.0095 1.23 
Y96 Y 10242.4206 10242.4138 -0.0068 -0.66 
Y120 Y 13015.7416 13015.7447 0.0031 0.24 
Y139 Y 14904.7323 14904.7339 0.0016 0.11 
[a] Calculated based on monoisotopic masses 
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APPENDIX C: SUPPORTING MATERIAL TO ACCOMPANY CHAPTER 4 
Table C.1. Structures, molecular weights, and synthetic reagents used to synthesize all 




Figure C.1. 193 nm UVPD (20 pulses, 4 mJ) mass spectra for FA 18:1(11Z) complexed 
to various dicationic compounds.  Dications were selected to minimize the 
presence of isobaric UVPD fragments from the dicationic and FA structures.  
(A) Structure of 18:1(11Z) complexed to 1,6-methyl dication (m/z 535.52) with labelled 
fragments from corresponding (B) UVPD spectrum. (C) Isobaric fragment structures 
confounding interpretation are shown. (D) Structure of 18:1(11Z) complexed to 1,8-
methyl dication (m/z 563.55) with labelled fragments from corresponding (E) UVPD 
spectrum. (F) Isobaric fragment structures confounding interpretation are shown. (G) 
Structure of 18:1(11Z) complexed to 1,6-ethyl (m/z 563.55) dication with labelled 
fragments from corresponding (H) UVPD spectrum. (I) Incorporation of an ethyl group 
on the quaternary amine results in separation of the confounding DC and FA fragment 
products in m/z space. Isobar signals and masses are highlighted in red font. Selected 
precursor ions are designated with a star.  
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APPENDIX D: SUPPORTING MATERIAL TO ACCOMPANY CHAPTER 5 
Table D.1. Information regarding the number/types of samples contributed by patient.  
Patient 
number 




Types of endometriosis 
lesions obtained 
3 -- 1 Peritoneum 
4 -- 1 Serosal 
5 -- 1 Serosal 
12 -- 1 Peritoneum 
13 -- 1 Peritoneum 
16 -- 2 
Peritoneum 
Adventital us ligament 




19 2 -- -- 
21 -- 3 
Adventital us ligament 
Adventital us ligament 
Peritoneum 
23 1 1 Adventital us ligament 
24 1  -- 
25 1 1 -- 
27 -- 3 
Peritoneum and Ligamentous 
Peritoneum and Ligamentous 
Adventital us ligament 
28 1 -- -- 
30 1 4 
Serosal 
Serosal 
Adventital us ligament 
Peritoneum and Ligamentous 
34 1   










Table D.1. (cont.) 
Patient 
number 




Types of endometriosis 
lesions obtained 
38 1 1 Peritoneum 




41 1 -- -- 
42 1 2 
Peritoneum 
Endometrioma 




48 1 -- -- 
49 1 -- -- 
50 -- 2 
Endometrioma 
Peritoneum 
51 -- 2 
Peritoneum 
Peritoneum 
52 -- 1 Serosal 
53 1 -- -- 




56 1 2 
Serosal 
Peritoneum 
59 1 -- -- 




67 -- 1 Peritoneum 
68 1 -- -- 
69 -- 1 Adventital us ligament 
71 -- 1 Peritoneum 
72 -- 1 Serosal 
74 -- 1 Peritoneum 
75 -- 1 Serosal 
76 -- 1 Cortex 
77 -- 2 Serosal 
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Table D.1. (cont.) 
Patient 
number 




Types of endometriosis 
lesions obtained 
77 -- 2 Peritoneum 
 
78 
-- 1 Serosal 
79 1 -- -- 
82 -- 3 
Peritoneum 
Adventital us ligament 
Serosal 
85 -- 2 
Adventital us ligament 
Serosal 
87 -- 1 Peritoneum 
88 -- 1 Peritoneum 
89 -- 1 Fallopian tube 
93 1 2 
Peritoneum 
Adventital us ligament 
96 1 -- -- 





If patients contributed ectopic endometrial samples, information about the location of 
excision is provided in the fourth column. Eutopic endometrial samples were all obtain 
from the uterus. 
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 Figure D.1. Visual representation of the nonparametric bootstrapping analysis 
The majority of features within our dataset differ significantly between the eutopic and 
ectopic endometrial tissue using a standard null hypothesis. All features with standard 
deviations (error bars) falling outside of a 0 value log-fold change will be returned with a 
p-value of approximately zero when using a traditional null hypothesis. 
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Figure D.2. Histogram of the z-values calculated from the observed log-ratio of mean ion 
intensities of the eutopic and ectopic endometrium tissue, divided by their 
standard error.  
The black lines overlaid on the histogram represent the estimated mixture density and the 
estimated null density, and selected “interesting” features are signified by green lines 










Table D.2. Summary of patient demographics for prospectively collected endometriosis 




Asian East Indian Hispanic White Other Unknown 
8 1 1 9 53 1 3 
Age 
≤20 20-29 30-39 40-49 ≥50 Median Mean 
1 11 34 28 2 38 37.8 
Note that some patients that contributed an endometriosis sample also contributed a 
eutopic endometrium sample, and thus the total number of patients (89) is not the sum of 
























Asian East Indian Hispanic White Other Unknown 
4 0 0 2 15 1 0 
Age 
≤20 20-29 30-39 40-49 ≥50 Median Mean 
0 0 16 6 0 37 38.2 
Note that some patients that contributed a eutopic endometrium sample also contributed 
one or more endometriosis samples, and thus the total number of patients (89) is not the 










Figure D.3. Example MS/MS data collected to identify metabolite species detected 
during DESI-MS imaging experiments of endometrium and endometriosis 




Figure D.4. Example MS/MS data collected to identify glycerophospholipid species 
detected during DESI-MS imaging experiments of endometrium and 
endometriosis lesions that were later selected as features within either lasso 





Figure D.5. DESI-MS imaging mass spectra from endometrial stroma region and 
surrounding connective tissue. 
The colored boxes on the optical image (Left) correspond to the endometrial stroma 
(Red) and the connective tissue (Blue) from which 5 spectra were averaged to display. 
The relative abundance for the endometrial stroma is about one order of magnitude more 
intense (NL: 3.76E4) compared to the connective tissue (NL: 4.86E3), hence the lower 
overall signal intensity exhibited throughout the ion images shown in the manuscript. 
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Figure D.6. DESI-MS imaging mass spectra from other regions of tissue involved in this 
study, including hemosiderin, inflammatory cells, and ovary. 
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Figure D.7. Intra-patient PCA score plots of eutopic endometrium and three endometriosis 







Figure D.8. Intra-patient PCA score plots of eutopic endometrium and three endometriosis 














Table D.4 Summary of menstrual cycle day information for samples used for the 
statistical analysis in this study.  
 




9 4 4 3 16.4 12.5 2 
Endometriosis 























Figure D.9. Comparison of eutopic endometrium (left) and endometriosis (right) glands 








Figure D.10. Tandem MS data of m/z 246.951 and proposed neutral loss fragments. Due 
to the fluorinated nature of this compound, it is most likely a derivatization 
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